Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer VCMap
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:molluscicide
go back to main search page
Accession:CHEBI:33904 term browser browse the term
Definition:A substance used to destroy pests of the phylum Mollusca.
Synonyms:related_synonym: molluscicides
 xref: Wikipedia:Molluscicide


show annotations for term's descendants           Sort by:
 
4-chloro-3,5-dimethylphenol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ar androgen receptor multiple interactions ISO chloroxylenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] CTD PMID:33049310 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions ISO chloroxylenol binds to and results in increased activity of ESR1 protein CTD PMID:33049310 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO chloroxylenol binds to and results in increased activity of ESR2 protein CTD PMID:33049310 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO chloroxylenol binds to and results in increased activity of NR1I2 protein CTD PMID:33049310 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO chloroxylenol binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Scn4a sodium voltage-gated channel alpha subunit 4 affects activity
multiple interactions		 ISO chloroxylenol affects the activity of SCN4A protein polymorphism
chloroxylenol binds to and results in decreased activity of SCN4A protein		 CTD PMID:11282107 PMID:14662728 NCBI chr10:91,246,936...91,296,670
Ensembl chr10:91,246,936...91,296,545 		JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO chloroxylenol binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916 		JBrowse link
aminocarb term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase decreases activity ISO aminocarb results in decreased activity of ACHE protein CTD PMID:2086312 NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
copper(I) chloride term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 affects binding
multiple interactions		 ISO [Chromones analog binds to cuprous chloride] which binds to AKT1 protein
[Chromones analog binds to cuprous chloride] which results in decreased activity of AKT1 protein		 CTD PMID:16789737 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases activity
increases expression		 ISO cuprous chloride results in increased activity of NQO1 protein
cuprous chloride results in increased expression of NQO1 mRNA		 CTD PMID:9029048 NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557 		JBrowse link
G S100a13 S100 calcium binding protein A13 multiple interactions ISO [Calcium Chloride co-treated with cuprous chloride] binds to and affects the folding of S100A13 protein; cuprous chloride binds to and affects the folding of S100A13 protein CTD PMID:16766622 NCBI chr 2:175,999,439...176,005,933 JBrowse link
G Tf transferrin multiple interactions ISO cuprous chloride inhibits the reaction [TF protein results in increased uptake of Iron] CTD PMID:11335103 NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511 		JBrowse link
cypermethrin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aass aminoadipate-semialdehyde synthase increases expression ISO cypermethrin results in increased expression of AASS mRNA CTD PMID:21142847 NCBI chr 4:51,606,461...51,663,136
Ensembl chr 4:51,606,462...51,663,136 		JBrowse link
G Abat 4-aminobutyrate aminotransferase decreases activity ISO cypermethrin results in decreased activity of ABAT protein CTD PMID:24220872 NCBI chr10:6,996,688...7,092,835
Ensembl chr10:6,999,819...7,092,835 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 decreases expression ISO cypermethrin results in decreased expression of ABCG1 mRNA CTD PMID:25424538 NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948 		JBrowse link
G Acer2 alkaline ceramidase 2 decreases expression ISO cypermethrin results in decreased expression of ACER2 mRNA CTD PMID:29020013 NCBI chr 5:101,391,830...101,442,615
Ensembl chr 5:101,391,885...101,442,614 		JBrowse link
G Ache acetylcholinesterase increases activity
affects activity
multiple interactions
decreases activity		 EXP cypermethrin results in increased activity of ACHE protein
cypermethrin affects the activity of ACHE protein
[cypermethrin co-treated with fenvalerate] results in decreased activity of ACHE protein; Chlorpyrifos promotes the reaction [cypermethrin results in decreased activity of ACHE protein]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased activity of ACHE protein]		 CTD PMID:7595515 PMID:8385837 PMID:10355540 PMID:32006337 NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Acot2 acyl-CoA thioesterase 2 decreases expression ISO cypermethrin results in decreased expression of ACOT2 mRNA CTD PMID:29020013 NCBI chr 6:103,611,744...103,619,404
Ensembl chr 6:103,611,544...103,619,245 		JBrowse link
G Acox1 acyl-CoA oxidase 1 multiple interactions ISO cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of ACOX1 mRNA] CTD PMID:24440342 NCBI chr10:101,406,197...101,431,242
Ensembl chr10:101,406,197...101,431,232 		JBrowse link
G Adal adenosine deaminase-like increases expression ISO cypermethrin results in increased expression of ADAL mRNA CTD PMID:29020013 NCBI chr 3:108,101,857...108,119,557
Ensembl chr 3:108,101,857...108,118,516 		JBrowse link
G Agt angiotensinogen affects expression
multiple interactions		 EXP cypermethrin affects the expression of AGT
Sesame Oil affects the reaction [cypermethrin affects the expression of AGT]		 CTD PMID:25816392 NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977 		JBrowse link
G Ahr aryl hydrocarbon receptor multiple interactions ISO [prothioconazole co-treated with terbutylazine co-treated with bitertanol co-treated with cypermethrin co-treated with Malathion] results in increased activity of AHR protein; cypermethrin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of AHR protein] CTD PMID:25684042 NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 decreases expression
increases expression		 EXP
ISO		 cypermethrin results in decreased expression of AKT1 mRNA
cypermethrin results in increased expression of AKT1 mRNA		 CTD PMID:22528246 PMID:27704156 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Alb albumin decreases expression
multiple interactions
increases expression		 EXP cypermethrin results in decreased expression of ALB mRNA
Sesame Oil inhibits the reaction [cypermethrin results in increased expression of ALB]		 CTD PMID:9650644 PMID:11428908 PMID:25816392 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Aldh5a1 aldehyde dehydrogenase 5 family, member A1 decreases expression EXP cypermethrin results in decreased expression of ALDH5A1 mRNA CTD PMID:22528246 NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677 		JBrowse link
G Aldh8a1 aldehyde dehydrogenase 8 family, member A1 decreases expression ISO cypermethrin results in decreased expression of ALDH8A1 mRNA CTD PMID:25424538 NCBI chr 1:16,183,940...16,203,385
Ensembl chr 1:16,183,940...16,203,385 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions
increases activity		 ISO
EXP		 [cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein]
cypermethrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]
cypermethrin results in increased activity of ALPL protein		 CTD PMID:15365239 PMID:15991261 PMID:29149346 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446 		JBrowse link
G Als2 alsin Rho guanine nucleotide exchange factor ALS2 increases expression ISO cypermethrin results in increased expression of ALS2 mRNA CTD PMID:21142847 NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737 		JBrowse link
G Apaf1 apoptotic peptidase activating factor 1 increases expression ISO cypermethrin results in increased expression of APAF1 mRNA CTD PMID:27704156 NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540 		JBrowse link
G Apc APC regulator of WNT signaling pathway increases expression ISO
EXP		 cypermethrin results in increased expression of APC mRNA CTD PMID:21142847 PMID:22528246 NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696 		JBrowse link
G Apln apelin increases expression ISO cypermethrin results in increased expression of APLN mRNA CTD PMID:29020013 NCBI chr  X:127,180,801...127,213,567
Ensembl chr  X:127,203,823...127,213,391 		JBrowse link
G Aplnr apelin receptor increases expression ISO cypermethrin results in increased expression of APLNR mRNA CTD PMID:29020013 NCBI chr 3:70,217,407...70,221,052
Ensembl chr 3:70,217,385...70,221,050 		JBrowse link
G Apoa1 apolipoprotein A1 increases expression EXP cypermethrin results in increased expression of APOA1 mRNA CTD PMID:9650644 NCBI chr 8:46,527,251...46,529,035
Ensembl chr 8:46,527,144...46,529,035 		JBrowse link
G Apob apolipoprotein B increases expression EXP cypermethrin results in increased expression of APOB mRNA CTD PMID:9650644 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497 		JBrowse link
G Apoe apolipoprotein E decreases expression
increases expression		 EXP
ISO		 cypermethrin results in decreased expression of APOE mRNA
cypermethrin results in increased expression of APOE mRNA		 CTD PMID:9650644 PMID:11428908 PMID:21142847 NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932 		JBrowse link
G Aqr aquarius intron-binding spliceosomal factor increases expression ISO cypermethrin results in increased expression of AQR mRNA CTD PMID:21142847 NCBI chr 3:100,874,987...100,945,026
Ensembl chr 3:100,874,987...100,945,044 		JBrowse link
G Ar androgen receptor multiple interactions
decreases expression
decreases activity		 ISO
EXP		 [bitertanol co-treated with propiconazole co-treated with cypermethrin] inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; [Dihydrotestosterone co-treated with cypermethrin] results in decreased expression of AR mRNA; [terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion] inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]; [terbutylazine co-treated with bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion] results in decreased activity of AR protein; cypermethrin inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; cypermethrin inhibits the reaction [Metribolone results in increased activity of AR protein]
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA
cypermethrin inhibits the reaction [AR protein binds to SRC protein]
cypermethrin results in decreased expression of AR protein
cypermethrin results in decreased expression of AR mRNA; cypermethrin results in decreased expression of AR protein
cypermethrin results in decreased activity of AR protein		 CTD PMID:16857237 PMID:17980950 PMID:18324785 PMID:20410157 PMID:22147539 More... NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Arg1 arginase 1 multiple interactions ISO cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of ARG1 mRNA] CTD PMID:29471534 NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422 		JBrowse link
G Armcx5 armadillo repeat containing, X-linked 5 decreases expression ISO cypermethrin results in decreased expression of ARMCX5 mRNA CTD PMID:29020013 NCBI chr  X:98,709,592...98,747,326
Ensembl chr  X:98,709,841...98,714,674 		JBrowse link
G Atg12 autophagy related 12 increases expression ISO cypermethrin results in increased expression of ATG12 mRNA CTD PMID:27704156 NCBI chr18:39,452,247...39,462,424
Ensembl chr18:39,452,191...39,462,418 		JBrowse link
G Atg3 autophagy related 3 increases expression ISO cypermethrin results in increased expression of ATG3 mRNA CTD PMID:27704156 NCBI chr11:55,624,928...55,653,212
Ensembl chr11:55,624,917...55,653,224 		JBrowse link
G Atg5 autophagy related 5 increases expression ISO cypermethrin results in increased expression of ATG5 mRNA CTD PMID:27704156 NCBI chr20:47,798,222...47,889,216
Ensembl chr20:47,798,290...47,889,209 		JBrowse link
G Atg7 autophagy related 7 increases expression ISO cypermethrin results in increased expression of ATG7 mRNA CTD PMID:27704156 NCBI chr 4:147,718,663...147,925,656
Ensembl chr 4:147,718,752...147,925,593 		JBrowse link
G Atm ATM serine/threonine kinase increases expression ISO cypermethrin results in increased expression of ATM mRNA CTD PMID:21142847 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437 		JBrowse link
G Atp5mk ATP synthase membrane subunit k decreases expression ISO cypermethrin results in decreased expression of ATP5MD mRNA CTD PMID:29020013 NCBI chr 1:245,973,910...245,980,702
Ensembl chr 1:245,973,914...245,980,761 		JBrowse link
G Atp5pd ATP synthase peripheral stalk subunit d decreases expression
multiple interactions		 EXP cypermethrin results in decreased expression of ATP5H protein
Minocycline inhibits the reaction [cypermethrin results in decreased expression of ATP5H protein]		 CTD PMID:21561882 NCBI chr10:100,657,700...100,662,960
Ensembl chr10:100,657,708...100,663,479 		JBrowse link
G Atp6v1f ATPase H+ transporting V1 subunit F increases expression EXP cypermethrin results in increased expression of ATP6V1F mRNA CTD PMID:22528246 NCBI chr 4:58,067,666...58,070,628 JBrowse link
G Atp6v1g2 ATPase H+ transporting V1 subunit G2 increases expression ISO cypermethrin results in increased expression of ATP6V1G2 mRNA CTD PMID:27704156 NCBI chr20:3,587,681...3,591,309
Ensembl chr20:3,587,686...3,590,481 		JBrowse link
G Atrx ATRX, chromatin remodeler increases expression ISO cypermethrin results in increased expression of ATRX mRNA CTD PMID:21142847 NCBI chr  X:70,850,981...70,997,330
Ensembl chr  X:70,850,981...70,997,330 		JBrowse link
G B3galt4 Beta-1,3-galactosyltransferase 4 increases expression ISO cypermethrin results in increased expression of B3GALT4 mRNA CTD PMID:29020013 NCBI chr20:4,936,089...4,937,664
Ensembl chr20:4,931,768...4,938,315 		JBrowse link
G Bambi BMP and activin membrane-bound inhibitor increases expression ISO cypermethrin results in increased expression of BAMBI mRNA CTD PMID:29020013 NCBI chr17:54,121,251...54,125,816
Ensembl chr17:54,121,255...54,126,060 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
affects localization		 EXP
ISO		 cypermethrin results in increased expression of BAX mRNA; cypermethrin results in increased expression of BAX protein
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of BAX mRNA]
cypermethrin affects the localization of BAX protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA; Cyclosporine inhibits the reaction [cypermethrin affects the localization of BAX protein]; HBEGF protein inhibits the reaction [cypermethrin results in increased expression of BAX protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [cypermethrin affects the localization of BAX protein]		 CTD PMID:22048644 PMID:22528246 PMID:25370934 PMID:29945211 PMID:32028016 More... NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
increases expression
decreases expression		 EXP
ISO		 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA; HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein]
cypermethrin results in increased expression of BCL2 mRNA
cypermethrin results in decreased expression of BCL2 mRNA; cypermethrin results in decreased expression of BCL2 protein		 CTD PMID:22048644 PMID:22528246 PMID:27704156 PMID:32028016 PMID:33396045 NCBI chr13:22,689,783...22,853,920 JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
increases expression
decreases expression		 EXP
ISO		 HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2L1 protein]
cypermethrin results in increased expression of BCL2L1 mRNA		 CTD PMID:22048644 PMID:27704156 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 		JBrowse link
G Bcl6 BCL6, transcription repressor multiple interactions ISO [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein; [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; [[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein; [cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA CTD PMID:29471534 NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389 		JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions
increases expression		 ISO
EXP		 cypermethrin inhibits the reaction [Veratridine results in increased expression of BDNF mRNA]
cypermethrin results in increased expression of BDNF mRNA		 CTD PMID:11082455 PMID:16166269 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615 		JBrowse link
G Birc2 baculoviral IAP repeat-containing 2 increases expression ISO cypermethrin results in increased expression of BIRC2 mRNA CTD PMID:27704156 NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732 		JBrowse link
G Bmf Bcl2 modifying factor increases expression ISO cypermethrin results in increased expression of BMF mRNA CTD PMID:27704156 NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145 		JBrowse link
G Bnip3 BCL2 interacting protein 3 increases expression ISO cypermethrin results in increased expression of BNIP3 mRNA CTD PMID:32028016 NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase increases expression EXP cypermethrin results in increased expression of BRAF mRNA CTD PMID:22528246 NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463 		JBrowse link
G Brdt bromodomain testis associated multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA CTD PMID:33051911 PMID:33396045 NCBI chr14:2,421,094...2,445,842
Ensembl chr14:2,387,796...2,445,842 		JBrowse link
G C1galt1c1 C1GALT1-specific chaperone 1 increases expression ISO cypermethrin results in increased expression of C1GALT1C1 mRNA CTD PMID:29020013 NCBI chr  X:117,378,123...117,382,620
Ensembl chr  X:117,375,525...117,382,787 		JBrowse link
G Camk2a calcium/calmodulin-dependent protein kinase II alpha increases expression ISO cypermethrin results in increased expression of CAMK2A mRNA CTD PMID:32028016 NCBI chr18:54,378,642...54,441,120
Ensembl chr18:54,378,784...54,438,994 		JBrowse link
G Camk2b calcium/calmodulin-dependent protein kinase II beta increases expression ISO cypermethrin results in increased expression of CAMK2B mRNA CTD PMID:32028016 NCBI chr14:80,845,206...80,934,172
Ensembl chr14:80,845,238...80,933,994 		JBrowse link
G Casp1 caspase 1 increases expression EXP cypermethrin results in increased expression of CASP1 mRNA CTD PMID:22528246 NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383 		JBrowse link
G Casp3 caspase 3 multiple interactions
increases activity
increases expression		 ISO
EXP		 Acetylcysteine inhibits the reaction [cypermethrin results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP3 mRNA]; cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased cleavage of and results in increased activity of CASP3 protein]
cypermethrin results in increased expression of CASP3 protein
[cypermethrin co-treated with Chlorpyrifos co-treated with profenofos] results in increased cleavage of CASP3 protein
cypermethrin results in increased cleavage of and results in increased activity of CASP3 protein		 CTD PMID:11341974 PMID:21987380 PMID:22048644 PMID:25370934 PMID:27704156 More... NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp6 caspase 6 increases expression EXP cypermethrin results in increased expression of CASP6 mRNA CTD PMID:22528246 NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502 		JBrowse link
G Casp7 caspase 7 multiple interactions
increases expression		 EXP
ISO		 cypermethrin results in increased cleavage of and results in increased activity of CASP7 protein
cypermethrin results in increased expression of CASP7 mRNA		 CTD PMID:22048644 PMID:27704156 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression		 EXP
ISO		 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA; cypermethrin results in increased cleavage of and results in increased activity of CASP9 protein
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of CASP9 mRNA]		 CTD PMID:22048644 PMID:22528246 PMID:27704156 PMID:29945211 PMID:33396045 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Cat catalase multiple interactions
affects binding
decreases activity
affects activity
increases expression
increases activity		 ISO
EXP		 [cypermethrin co-treated with Chlorpyrifos] results in decreased activity of CAT protein; [propetamphos co-treated with cypermethrin] results in decreased activity of CAT protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of CAT protein]
cypermethrin binds to CAT protein
cypermethrin results in decreased activity of CAT protein
cypermethrin affects the activity of CAT protein
cypermethrin results in increased expression of CAT mRNA
cypermethrin results in increased activity of CAT protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with fenvalerate] results in increased activity of CAT protein; [cypermethrin co-treated with propetamphos] results in decreased activity of CAT protein; Sesame Oil affects the reaction [cypermethrin affects the activity of CAT protein]		 CTD PMID:10355540 PMID:12965126 PMID:15365239 PMID:15991261 PMID:18214882 More... NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions ISO cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of CCL7 mRNA] CTD PMID:29471534 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303 		JBrowse link
G Ccna1 cyclin A1 decreases expression ISO cypermethrin results in decreased expression of CCNA1 mRNA CTD PMID:24810582 NCBI chr 2:139,231,738...139,278,066
Ensembl chr 2:139,201,074...139,243,157 		JBrowse link
G Ccna2 cyclin A2 decreases expression EXP cypermethrin results in decreased expression of CCNA2 mRNA CTD PMID:22528246 NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577 		JBrowse link
G Ccnd1 cyclin D1 increases expression
multiple interactions		 ISO cypermethrin results in increased expression of CCND1 mRNA
fulvestrant inhibits the reaction [cypermethrin results in increased expression of CCND1 mRNA]		 CTD PMID:26877835 NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccnd2 cyclin D2 increases expression
decreases expression		 EXP
ISO		 cypermethrin results in increased expression of CCND2 mRNA
cypermethrin results in decreased expression of CCND2 mRNA		 CTD PMID:22528246 PMID:24810582 NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495 		JBrowse link
G Ccs copper chaperone for superoxide dismutase increases expression ISO cypermethrin results in increased expression of CCS mRNA CTD PMID:21142847 NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915 		JBrowse link
G Cd9 CD9 molecule multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222 		JBrowse link
G Cd93 CD93 molecule increases expression ISO cypermethrin results in increased expression of CD93 mRNA CTD PMID:29020013 NCBI chr 3:135,891,859...135,898,378
Ensembl chr 3:135,891,859...135,898,378 		JBrowse link
G Cdh12 cadherin 12 increases expression EXP cypermethrin results in increased expression of CDH12 mRNA CTD PMID:22528246 NCBI chr 2:70,474,679...71,705,369
Ensembl chr 2:70,475,043...71,700,572 		JBrowse link
G Cdk9 cyclin-dependent kinase 9 decreases expression EXP cypermethrin results in decreased expression of CDK9 mRNA CTD PMID:22528246 NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410 		JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B increases expression EXP cypermethrin results in increased expression of CDKN2B mRNA CTD PMID:22528246 NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050 		JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D decreases expression EXP cypermethrin results in decreased expression of CDKN2D mRNA CTD PMID:22528246 NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674 		JBrowse link
G Cebpe CCAAT/enhancer binding protein epsilon multiple interactions ISO Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of CEBPE mRNA] CTD PMID:29945211 NCBI chr15:28,169,885...28,171,283
Ensembl chr15:28,169,704...28,171,814 		JBrowse link
G Cenpa centromere protein A increases expression ISO cypermethrin results in increased expression of CENPA mRNA CTD PMID:29020013 NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675 		JBrowse link
G Ces1d carboxylesterase 1D increases hydrolysis ISO CES1 protein results in increased hydrolysis of cypermethrin CTD PMID:16359636 NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035 		JBrowse link
G Ces2h carboxylesterase 2H increases hydrolysis ISO CES2 protein results in increased hydrolysis of cypermethrin CTD PMID:16359636 NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830 		JBrowse link
G Cga glycoprotein hormones, alpha polypeptide increases expression
multiple interactions		 ISO cypermethrin results in increased expression of CGA mRNA
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of CGA mRNA]		 CTD PMID:28731686 PMID:29149324 NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191 		JBrowse link
G Chac1 ChaC glutathione-specific gamma-glutamylcyclotransferase 1 increases expression ISO cypermethrin results in increased expression of CHAC1 mRNA CTD PMID:25424538 NCBI chr 3:106,342,302...106,345,526
Ensembl chr 3:106,342,302...106,345,526 		JBrowse link
G Chat choline O-acetyltransferase decreases expression EXP cypermethrin results in decreased expression of CHAT mRNA; cypermethrin results in decreased expression of CHAT protein CTD PMID:26115703 NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093 		JBrowse link
G Chchd2l3 coiled-coil-helix-coiled-coil-helix domain containing protein 2-like 3 increases expression ISO cypermethrin results in increased expression of CHCHD2 mRNA CTD PMID:29020013 NCBI chr 9:94,500,439...94,501,110
NCBI chr 9:94,500,629...94,501,122
Ensembl chr 9:94,500,432...94,501,128 		JBrowse link
G Chrm2 cholinergic receptor, muscarinic 2 multiple interactions
decreases expression		 EXP cypermethrin promotes the reaction [cypermethrin results in decreased expression of CHRM2 mRNA]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of CHRM2 protein]
cypermethrin results in decreased expression of CHRM2 mRNA; cypermethrin results in decreased expression of CHRM2 protein		 CTD PMID:25288152 NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103 		JBrowse link
G Ciita class II, major histocompatibility complex, transactivator multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA CTD PMID:33051911 PMID:33396045 NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440 		JBrowse link
G Cldn5 claudin 5 increases expression ISO cypermethrin results in increased expression of CLDN5 mRNA CTD PMID:29020013 NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992 		JBrowse link
G Clu clusterin multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA CTD PMID:33051911 NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315 		JBrowse link
G Commd4 COMM domain containing 4 increases expression ISO cypermethrin results in increased expression of COMMD4 mRNA CTD PMID:27704156 NCBI chr 8:57,566,236...57,569,794
Ensembl chr 8:57,566,236...57,569,760 		JBrowse link
G Copg2 COPI coat complex subunit gamma 2 decreases expression EXP cypermethrin results in decreased expression of COPG2 mRNA CTD PMID:22528246 NCBI chr 4:59,366,086...59,501,591
Ensembl chr 4:59,366,086...59,501,618 		JBrowse link
G Cox14 cytochrome c oxidase assembly factor COX14 increases expression ISO cypermethrin results in increased expression of COX14 mRNA CTD PMID:29020013 NCBI chr 7:130,852,226...130,854,316 JBrowse link
G Cox7c cytochrome c oxidase subunit 7C decreases expression ISO cypermethrin results in decreased expression of COX7C mRNA CTD PMID:29020013 NCBI chr 2:16,841,771...16,843,796
Ensembl chr 2:16,840,837...16,843,760 		JBrowse link
G Cpt1a carnitine palmitoyltransferase 1A multiple interactions ISO cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of CPT1A mRNA] CTD PMID:24440342 NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055 		JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions ISO
EXP		 [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of CREB1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA		 CTD PMID:30974244 PMID:33051911 PMID:33396045 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816 		JBrowse link
G Crebbp CREB binding protein multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA CTD PMID:33051911 PMID:33396045 NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888 		JBrowse link
G Crem cAMP responsive element modulator multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA CTD PMID:33396045 NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989 		JBrowse link
G Crlf1 cytokine receptor-like factor 1 decreases expression EXP cypermethrin results in decreased expression of CRLF1 mRNA CTD PMID:22528246 NCBI chr16:18,924,722...18,936,049
Ensembl chr16:18,924,722...18,935,997 		JBrowse link
G Cry2 cryptochrome circadian regulator 2 increases expression ISO cypermethrin results in increased expression of CRY2 mRNA CTD PMID:21142847 NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965 		JBrowse link
G Csf3r colony stimulating factor 3 receptor multiple interactions ISO Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of CSF3R mRNA] CTD PMID:29945211 NCBI chr 5:138,298,605...138,318,224
Ensembl chr 5:138,301,506...138,317,881 		JBrowse link
G Ctsb cathepsin B increases expression ISO cypermethrin results in increased expression of CTSB mRNA CTD PMID:27704156 NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500 		JBrowse link
G Cybb cytochrome b-245 beta chain multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA CTD PMID:33396045 NCBI chr  X:13,360,583...13,392,517
Ensembl chr  X:13,359,430...13,392,586 		JBrowse link
G Cycs cytochrome c, somatic affects localization
increases activity
multiple interactions		 EXP cypermethrin affects the localization of CYCS protein
cypermethrin results in increased activity of CYCS protein
[propetamphos co-treated with cypermethrin] results in increased activity of CYCS protein		 CTD PMID:22528246 PMID:25926273 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 		JBrowse link
G Cygb cytoglobin increases expression ISO cypermethrin results in increased expression of CYGB mRNA CTD PMID:21142847 NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442 		JBrowse link
G Cyld CYLD lysine 63 deubiquitinase increases expression ISO cypermethrin results in increased expression of CYLD mRNA CTD PMID:27704156 NCBI chr19:18,310,632...18,373,696
Ensembl chr19:18,314,019...18,373,658 		JBrowse link
G Cyp11a1 cytochrome P450, family 11, subfamily a, polypeptide 1 decreases expression
multiple interactions
increases expression		 ISO
EXP		 cypermethrin results in decreased expression of CYP11A1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA
cypermethrin results in increased expression of CYP11A1 mRNA
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of CYP11A1 mRNA]		 CTD PMID:20131380 PMID:21560301 PMID:24810582 PMID:28731686 PMID:33051911 More... NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 decreases expression
multiple interactions		 ISO
EXP		 cypermethrin results in decreased expression of CYP17A1 mRNA; cypermethrin results in decreased expression of CYP17A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA		 CTD PMID:21397294 PMID:21560301 PMID:24810582 PMID:33051911 PMID:33396045 NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573 		JBrowse link
G Cyp19a1 cytochrome P450, family 19, subfamily a, polypeptide 1 increases activity
increases expression
multiple interactions		 ISO
EXP		 cypermethrin results in increased activity of CYP19A1 protein
cypermethrin results in increased expression of CYP19A1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [bitertanol co-treated with propiconazole co-treated with cypermethrin co-treated with Malathion co-treated with terbutylazine] results in increased expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA		 CTD PMID:16996190 PMID:23954766 PMID:24810582 PMID:33051911 PMID:33396045 NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 decreases activity
affects expression
increases expression		 ISO
EXP		 cypermethrin results in decreased activity of CYP1A1 protein
cypermethrin affects the expression of CYP1A1 mRNA
cypermethrin results in increased expression of CYP1A1 mRNA		 CTD PMID:18420780 PMID:23447098 PMID:26115703 PMID:32214279 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity
increases expression		 ISO
EXP		 cypermethrin results in decreased activity of CYP1A2 protein
cypermethrin results in increased expression of CYP1A2 mRNA		 CTD PMID:18420780 PMID:23447098 PMID:26115703 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity
affects expression
increases expression		 ISO cypermethrin results in decreased activity of CYP1B1 protein
cypermethrin affects the expression of CYP1B1 mRNA
cypermethrin results in increased expression of CYP1B1		 CTD PMID:18420780 PMID:32214279 NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917 		JBrowse link
G Cyp26b1 cytochrome P450, family 26, subfamily b, polypeptide 1 multiple interactions
decreases expression		 ISO Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of CYP26B1 mRNA] CTD PMID:31659573 NCBI chr 4:117,041,808...117,058,628
Ensembl chr 4:117,041,808...117,058,628 		JBrowse link
G Cyp2a3 cytochrome P450, family 2, subfamily a, polypeptide 3 increases expression ISO cypermethrin results in increased expression of CYP2A4 mRNA CTD PMID:22310298 NCBI chr 1:82,171,914...82,179,980
Ensembl chr 1:82,169,949...82,179,979 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 decreases activity
multiple interactions
increases expression		 ISO
EXP		 cypermethrin results in decreased activity of CYP2B10 protein
Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP2B10 mRNA]
cypermethrin results in increased expression of CYP2B1 mRNA		 CTD PMID:11377398 PMID:18420780 PMID:23447098 PMID:26115703 PMID:31659573 NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 increases expression EXP cypermethrin results in increased expression of CYP2B2 mRNA CTD PMID:23447098 PMID:26115703 NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 increases activity
increases expression		 ISO cypermethrin results in increased activity of CYP2B6 protein
cypermethrin results in increased expression of CYP2B6 mRNA; cypermethrin results in increased expression of CYP2B6 protein		 CTD PMID:15548381 PMID:22310298 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases expression ISO cypermethrin results in increased expression of CYP2C19 mRNA CTD PMID:22310298 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 increases expression
decreases activity		 ISO cypermethrin results in increased expression of CYP2C8 mRNA
cypermethrin results in decreased activity of CYP2C29 protein		 CTD PMID:18420780 PMID:22310298
G Cyp2d1 cytochrome P450, family 2, subfamily d, polypeptide 1 multiple interactions
increases expression		 EXP cypermethrin promotes the reaction [cypermethrin results in increased expression of CYP2D1 mRNA]; cypermethrin promotes the reaction [cypermethrin results in increased expression of CYP2D1 protein]
cypermethrin results in increased expression of CYP2D1 mRNA; cypermethrin results in increased expression of CYP2D1 protein		 CTD PMID:25288152 NCBI chr 7:113,908,950...113,913,420
Ensembl chr 7:113,908,947...113,922,084 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 decreases activity ISO cypermethrin results in decreased activity of CYP2D6 protein CTD PMID:18420780 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity
increases activity
multiple interactions
increases expression		 ISO
EXP		 cypermethrin results in decreased activity of CYP2E1 protein
cypermethrin results in increased activity of CYP2E1 protein
[cypermethrin co-treated with propetamphos] results in increased activity of CYP2E1 protein
cypermethrin results in increased expression of CYP2E1 mRNA; cypermethrin results in increased expression of CYP2E1 protein
cypermethrin inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone]		 CTD PMID:18420780 PMID:20815782 PMID:22634058 PMID:23447098 PMID:25926273 More... NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases expression
decreases activity
increases activity		 ISO cypermethrin results in increased expression of CYP3A4 mRNA; cypermethrin results in increased expression of CYP3A4 protein
cypermethrin results in decreased activity of CYP3A4 protein
cypermethrin results in increased activity of CYP3A4 protein		 CTD PMID:15548381 PMID:18420780 PMID:22310298 PMID:22634058 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Cyp3a23-3a1 cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1 multiple interactions
increases expression		 EXP cypermethrin promotes the reaction [cypermethrin results in increased expression of CYP3A23-3A1 mRNA]; cypermethrin promotes the reaction [cypermethrin results in increased expression of CYP3A23-3A1 protein]
cypermethrin results in increased expression of CYP3A23-3A1 mRNA; cypermethrin results in increased expression of CYP3A23-3A1 protein		 CTD PMID:25288152 NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression
multiple interactions		 ISO cypermethrin results in increased expression of CYP3A13 mRNA
Sodium Selenite inhibits the reaction [cypermethrin results in increased expression of CYP3A13 mRNA]		 CTD PMID:31659573 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422 		JBrowse link
G Dap3 death associated protein 3 increases expression EXP cypermethrin results in increased expression of DAP3 mRNA CTD PMID:22528246 NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:174,318,983...174,346,461 		JBrowse link
G Dazap1 DAZ associated protein 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818 		JBrowse link
G Dbi diazepam binding inhibitor decreases expression ISO cypermethrin results in decreased expression of DBI mRNA CTD PMID:29020013 NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693 		JBrowse link
G Ddx25 DEAD-box helicase 25 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764 		JBrowse link
G Ddx3 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA CTD PMID:33051911 PMID:33396045 NCBI chr  Y:1,115,095...1,135,754
Ensembl chr  Y:1,116,309...1,135,706 		JBrowse link
G Dennd4a DENN domain containing 4A increases expression ISO cypermethrin results in increased expression of DENND4A mRNA CTD PMID:27704156 NCBI chr 8:65,322,920...65,436,331
Ensembl chr 8:65,322,941...65,436,330 		JBrowse link
G Depp1 DEPP1, autophagy regulator decreases expression ISO cypermethrin results in decreased expression of DEPP1 mRNA CTD PMID:29020013 NCBI chr 4:149,910,794...149,913,013
Ensembl chr 4:149,910,779...149,914,542 		JBrowse link
G Dgat1 diacylglycerol O-acyltransferase 1 multiple interactions ISO [lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of DGAT1 mRNA CTD PMID:24440342 NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 decreases expression
multiple interactions		 ISO cypermethrin results in decreased expression of DHRS9 mRNA
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of DHRS9 mRNA]		 CTD PMID:31659573 NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:54,147,803...54,220,241 		JBrowse link
G Dmrta1 DMRT-like family A1 increases expression ISO cypermethrin results in increased expression of DMRTA1 mRNA CTD PMID:29020013 NCBI chr 5:104,415,893...104,422,433
Ensembl chr 5:104,415,893...104,422,433 		JBrowse link
G Dnmt1 DNA methyltransferase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA CTD PMID:33051911 NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659 		JBrowse link
G Dnmt3a DNA methyltransferase 3 alpha multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687 		JBrowse link
G Dnmt3b DNA methyltransferase 3 beta multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 3:142,130,592...142,169,124
Ensembl chr 3:142,130,592...142,169,124 		JBrowse link
G Drd2 dopamine receptor D2 multiple interactions
decreases expression		 EXP cypermethrin inhibits the reaction [[Quinpirole binds to and results in increased activity of DRD2 protein] which results in increased uptake of Dopamine]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of DRD2 mRNA]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of DRD2 protein]
cypermethrin results in decreased expression of DRD2 mRNA; cypermethrin results in decreased expression of DRD2 protein		 CTD PMID:10936494 PMID:25288152 NCBI chr 8:49,708,903...49,772,888
Ensembl chr 8:49,708,927...49,772,875 		JBrowse link
G Duox1 dual oxidase 1 increases expression ISO cypermethrin results in increased expression of DUOX1 mRNA CTD PMID:21142847 NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:109,262,397...109,295,563 		JBrowse link
G Egfr epidermal growth factor receptor affects binding
multiple interactions
decreases phosphorylation
decreases expression		 EXP
ISO		 cypermethrin binds to EGFR protein
[cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of EGFR protein
cypermethrin results in decreased phosphorylation of EGFR protein
cypermethrin results in decreased expression of EGFR mRNA; cypermethrin results in decreased expression of EGFR protein		 CTD PMID:22048644 PMID:30974244 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Egr1 early growth response 1 multiple interactions
increases expression		 ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of EGR1 protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of EGR1 protein]; cypermethrin inhibits the reaction [Dihydrotestosterone results in increased expression of EGR1 mRNA]; cypermethrin inhibits the reaction [Dihydrotestosterone results in increased expression of EGR1 protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of EGR1 protein]
cypermethrin results in increased expression of EGR1 mRNA; cypermethrin results in increased expression of EGR1 protein		 CTD PMID:29149324 PMID:30974244 NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E increases expression ISO cypermethrin results in increased expression of EIF4E mRNA CTD PMID:29020013 NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Ephx1 epoxide hydrolase 1 increases expression EXP cypermethrin results in increased expression of EPHX1 mRNA CTD PMID:22528246 NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235 		JBrowse link
G Ercc2 ERCC excision repair 2, TFIIH core complex helicase subunit decreases expression EXP cypermethrin results in decreased expression of ERCC2 mRNA CTD PMID:22528246 NCBI chr 1:79,033,342...79,047,102
Ensembl chr 1:79,033,326...79,047,102 		JBrowse link
G Ercc6 ERCC excision repair 6, chromatin remodeling factor increases expression ISO cypermethrin results in increased expression of ERCC6 mRNA CTD PMID:21142847 NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587 		JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
increases expression
decreases expression
affects binding
increases activity		 ISO
EXP		 cypermethrin binds to and results in increased activity of ESR1 protein; cypermethrin metabolite binds to and results in increased activity of ESR1 protein
cypermethrin inhibits the reaction [Estradiol results in increased activity of ESR1 protein]
cypermethrin results in increased expression of ESR1 mRNA; cypermethrin results in increased expression of ESR1 protein
cypermethrin results in decreased expression of ESR1 mRNA; cypermethrin results in decreased expression of ESR1 protein
cypermethrin binds to ESR1 protein
cypermethrin results in increased activity of ESR1 protein		 CTD PMID:12396874 PMID:15064155 PMID:16395479 PMID:20397420 PMID:20574910 More... NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 increases expression
multiple interactions		 ISO cypermethrin results in increased expression of ESR2 mRNA
cypermethrin binds to and results in increased activity of ESR2 protein		 CTD PMID:20574910 PMID:33049310 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362 		JBrowse link
G F3 coagulation factor III, tissue factor decreases expression ISO cypermethrin results in decreased expression of F3 mRNA CTD PMID:29020013 NCBI chr 2:209,827,061...209,838,666
Ensembl chr 2:209,826,959...209,838,668 		JBrowse link
G Fancc FA complementation group C increases expression ISO cypermethrin results in increased expression of FANCC mRNA CTD PMID:21142847 NCBI chr17:1,680,660...1,822,610
Ensembl chr17:1,681,324...1,829,376 		JBrowse link
G Fancg FA complementation group G increases expression ISO cypermethrin results in increased expression of FANCG mRNA CTD PMID:21142847 NCBI chr 5:57,230,287...57,240,067
Ensembl chr 5:57,231,685...57,240,029 		JBrowse link
G Fas Fas cell surface death receptor increases expression ISO cypermethrin results in increased expression of FAS mRNA CTD PMID:27704156 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591 		JBrowse link
G Fau FAU, ubiquitin like and ribosomal protein S30 fusion decreases expression ISO cypermethrin results in decreased expression of FAU mRNA CTD PMID:29020013 NCBI chr 1:203,350,226...203,351,741
Ensembl chr 1:203,350,189...203,351,742 		JBrowse link
G Fgf5 fibroblast growth factor 5 decreases expression ISO cypermethrin results in decreased expression of FGF5 mRNA CTD PMID:32214279 NCBI chr14:11,325,334...11,346,570
Ensembl chr14:11,325,334...11,345,997 		JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO cypermethrin results in increased expression of FMO2 mRNA CTD PMID:21142847 NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression		 ISO
EXP		 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of FOS protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of FOS protein]; cypermethrin inhibits the reaction [Veratridine results in increased expression of FOS mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FOS protein]
cypermethrin results in increased expression of FOS mRNA; cypermethrin results in increased expression of FOS protein		 CTD PMID:8856738 PMID:11082455 PMID:29149324 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Foxa2 forkhead box A2 increases expression ISO cypermethrin results in increased expression of FOXA2 mRNA CTD PMID:32214279 NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326 		JBrowse link
G Foxf2 forkhead box F2 decreases expression EXP cypermethrin results in decreased expression of FOXF2 mRNA CTD PMID:22528246 NCBI chr17:32,835,730...32,842,555
Ensembl chr17:32,836,777...32,842,176 		JBrowse link
G Fshb follicle stimulating hormone subunit beta increases expression
increases secretion
multiple interactions
decreases expression		 EXP
ISO		 cypermethrin results in increased expression of FSHB protein
cypermethrin results in increased secretion of FSHB protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; cypermethrin results in increased expression of and results in increased secretion of FSHB protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of FSHB mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased secretion of FSHB protein]
Vitamin E inhibits the reaction [cypermethrin results in decreased expression of FSHB protein]		 CTD PMID:23447098 PMID:24759048 PMID:28731686 PMID:29149324 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370 		JBrowse link
G Fshr follicle stimulating hormone receptor multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA; [cypermethrin co-treated with Diethylhexyl Phthalate] results in decreased expression of FSHR mRNA CTD PMID:24641848 PMID:33051911 PMID:33396045 NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785 		JBrowse link
G G6pd glucose-6-phosphate dehydrogenase multiple interactions
decreases activity		 EXP [cypermethrin co-treated with propetamphos] results in decreased activity of G6PD protein
cypermethrin results in decreased activity of G6PD protein		 CTD PMID:25926273 NCBI chr  X:152,201,081...152,220,863
Ensembl chr  X:152,201,098...152,220,801 		JBrowse link
G Gabra1 gamma-aminobutyric acid type A receptor subunit alpha 1 multiple interactions
decreases expression		 EXP cypermethrin promotes the reaction [cypermethrin results in decreased expression of GABRA1 mRNA]; cypermethrin promotes the reaction [cypermethrin results in decreased expression of GABRA1 protein]
cypermethrin results in decreased expression of GABRA1 mRNA; cypermethrin results in decreased expression of GABRA1 protein		 CTD PMID:25288152 NCBI chr10:26,595,151...26,650,611
Ensembl chr10:26,595,160...26,650,864 		JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 decreases expression ISO cypermethrin results in decreased expression of GABRG2 mRNA CTD PMID:24220872 NCBI chr10:26,376,805...26,463,680
Ensembl chr10:26,374,694...26,464,346 		JBrowse link
G Gad1 glutamate decarboxylase 1 decreases expression EXP cypermethrin results in decreased expression of GAD1 mRNA; cypermethrin results in decreased expression of GAD1 protein CTD PMID:26115703 NCBI chr 3:55,369,704...55,410,335
Ensembl chr 3:55,369,704...55,410,333 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible, alpha increases expression EXP
ISO		 cypermethrin results in increased expression of GADD45A mRNA CTD PMID:22528246 PMID:27704156 NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115 		JBrowse link
G Gap43 growth associated protein 43 increases expression ISO cypermethrin results in increased expression of GAP43 mRNA CTD PMID:32028016 NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045 		JBrowse link
G Gata2 GATA binding protein 2 decreases expression EXP cypermethrin results in decreased expression of GATA2 mRNA CTD PMID:22528246 NCBI chr 4:120,654,205...120,667,763
Ensembl chr 4:120,658,986...120,667,761 		JBrowse link
G Gata4 GATA binding protein 4 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA CTD PMID:33051911 NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636 		JBrowse link
G Gdnf glial cell derived neurotrophic factor multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209 		JBrowse link
G Gfra1 GDNF family receptor alpha 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473 		JBrowse link
G Gh1 growth hormone 1 decreases expression EXP cypermethrin results in decreased expression of GH1 protein CTD PMID:26115703 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078 		JBrowse link
G Gjc2 gap junction protein, gamma 2 increases expression
multiple interactions		 EXP cypermethrin results in increased expression of GJC2 protein modified form
Minocycline inhibits the reaction [cypermethrin results in increased expression of GJC2 protein modified form]		 CTD PMID:21561882 NCBI chr10:43,962,642...43,971,358
Ensembl chr10:43,962,642...43,970,467 		JBrowse link
G Glud1 glutamate dehydrogenase 1 increases expression ISO cypermethrin results in increased expression of GLUD1 mRNA CTD PMID:32573024 NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,640,312...9,673,957 		JBrowse link
G Glul glutamate-ammonia ligase decreases activity ISO cypermethrin results in decreased activity of GLUL protein CTD PMID:24649940 NCBI chr13:65,969,064...66,035,121
Ensembl chr13:66,025,630...66,035,108 		JBrowse link
G Gnrh1 gonadotropin releasing hormone 1 affects secretion ISO cypermethrin affects the secretion of GNRH1 protein CTD PMID:28731686 NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581
Ensembl chr15:41,972,905...41,973,581 		JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 multiple interactions
increases secretion
increases activity
decreases activity		 ISO
EXP		 [cypermethrin co-treated with Chlorpyrifos] results in increased expression of GOT1 protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of GOT1 protein]
cypermethrin results in increased secretion of GOT1 protein
Phenobarbital inhibits the reaction [cypermethrin results in increased secretion of GOT1 protein]; Proadifen promotes the reaction [cypermethrin results in increased secretion of GOT1 protein]
cypermethrin results in increased activity of GOT1 protein
cypermethrin results in decreased activity of GOT1 protein		 CTD PMID:2466999 PMID:11428908 PMID:15365239 PMID:15991261 NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633 		JBrowse link
G Got2 glutamic-oxaloacetic transaminase 2 increases expression
multiple interactions		 EXP cypermethrin results in increased expression of GOT2
Sesame Oil inhibits the reaction [cypermethrin results in increased expression of GOT2]		 CTD PMID:25816392 NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994 		JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions
increases expression
increases activity
increases secretion		 ISO
EXP		 [cypermethrin co-treated with Chlorpyrifos] results in increased expression of GPT protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of GPT protein]
cypermethrin results in increased expression of GPT mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein; Phenobarbital inhibits the reaction [cypermethrin results in increased secretion of GPT protein]; Proadifen promotes the reaction [cypermethrin results in increased secretion of GPT protein]; Sesame Oil inhibits the reaction [cypermethrin results in increased expression of GPT]
cypermethrin results in increased activity of GPT protein		 CTD PMID:11428908 PMID:15365239 PMID:15991261 PMID:25816392 PMID:32573024 More... NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494 		JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions
affects expression
increases expression		 ISO [cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GPX1 protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GPX1 protein]
cypermethrin affects the expression of GPX1 mRNA
cypermethrin results in increased expression of GPX1 mRNA		 CTD PMID:15991261 PMID:21397294 PMID:32214279 NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024 		JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression ISO cypermethrin results in increased expression of GPX2 mRNA CTD PMID:21397294 NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877 		JBrowse link
G Gpx4 glutathione peroxidase 4 increases expression ISO cypermethrin results in increased expression of GPX4 mRNA CTD PMID:21142847 PMID:32214279 NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982 		JBrowse link
G Grb2 growth factor receptor bound protein 2 decreases expression ISO cypermethrin results in decreased expression of GRB2 mRNA CTD PMID:27704156 NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309 		JBrowse link
G Gria1 glutamate ionotropic receptor AMPA type subunit 1 affects expression ISO cypermethrin affects the expression of GRIA1 protein CTD PMID:26143737 NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283 		JBrowse link
G Grin2a glutamate ionotropic receptor NMDA type subunit 2A decreases expression EXP cypermethrin results in decreased expression of GRIN2A protein CTD PMID:28975519 NCBI chr10:5,630,684...6,043,341
Ensembl chr10:5,631,369...6,044,637 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B decreases expression EXP cypermethrin results in decreased expression of GRIN2B protein CTD PMID:28975519 NCBI chr 4:168,580,824...169,044,110
Ensembl chr 4:168,599,546...169,042,279 		JBrowse link
G Grp gastrin releasing peptide increases expression ISO cypermethrin results in increased expression of GRP mRNA CTD PMID:29020013 NCBI chr18:59,388,679...59,402,061
Ensembl chr18:59,388,274...59,402,061 		JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions
increases expression		 ISO [cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GSR protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of GSR protein]
cypermethrin results in increased expression of GSR mRNA		 CTD PMID:15991261 PMID:21142847 NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661 		JBrowse link
G Gsta4 glutathione S-transferase alpha 4 increases expression EXP cypermethrin results in increased expression of GSTA4 mRNA CTD PMID:20815782 NCBI chr 8:79,066,967...79,084,193
Ensembl chr 8:79,066,934...79,084,182 		JBrowse link
G Gsta5 glutathione S-transferase alpha 5 increases expression ISO cypermethrin results in increased expression of GSTA1; cypermethrin results in increased expression of GSTA1 mRNA CTD PMID:32214279 NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472 		JBrowse link
G Gstk1 glutathione S-transferase kappa 1 increases expression ISO cypermethrin results in increased expression of GSTK1 mRNA CTD PMID:21142847 NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292 		JBrowse link
G Gstp1 glutathione S-transferase pi 1 decreases expression EXP cypermethrin results in decreased expression of GSTP1 mRNA CTD PMID:22528246 NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226 		JBrowse link
G Gtf2h1 general transcription factor IIH subunit 1 increases expression ISO cypermethrin results in increased expression of GTF2H1 mRNA CTD PMID:21142847 NCBI chr 1:97,321,401...97,349,455
Ensembl chr 1:97,321,394...97,349,455 		JBrowse link
G H1f2 H1.2 linker histone, cluster member decreases expression ISO cypermethrin results in decreased expression of H1F2 mRNA CTD PMID:29020013 NCBI chr17:41,391,106...41,392,611
Ensembl chr17:41,388,477...41,392,635 		JBrowse link
G Hba-a2 hemoglobin alpha, adult chain 2 decreases expression ISO cypermethrin results in decreased expression of HBA-A2 mRNA CTD PMID:29020013 NCBI chr10:15,323,830...15,324,677
Ensembl chr10:15,307,815...15,338,392 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor multiple interactions
decreases response to substance
decreases expression		 EXP cypermethrin results in decreased expression of and results in decreased secretion of HBEGF protein; HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein]; HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2L1 protein]; HBEGF protein inhibits the reaction [cypermethrin results in increased expression of BAX protein]
HBEGF protein results in decreased susceptibility to cypermethrin
cypermethrin results in decreased expression of HBEGF mRNA		 CTD PMID:22048644 NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441 		JBrowse link
G Hdac1 histone deacetylase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111 		JBrowse link
G Hdac10 histone deacetylase 10 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228 		JBrowse link
G Hdac4 histone deacetylase 4 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA CTD PMID:33396045 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hist1h2bl histone cluster 1 H2B family member l decreases expression ISO cypermethrin results in decreased expression of H2BC7 mRNA CTD PMID:29020013 NCBI chr17:42,708,646...42,709,435 JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-CoA reductase multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-CoA synthase 1 decreases expression
multiple interactions		 ISO
EXP		 cypermethrin results in decreased expression of HMGCS1 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA		 CTD PMID:21397294 PMID:33051911 PMID:33396045 NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100 		JBrowse link
G Hmox1 heme oxygenase 1 affects expression
decreases expression
multiple interactions
increases expression		 EXP
ISO		 cypermethrin affects the expression of HMOX1
cypermethrin results in decreased expression of HMOX1 mRNA; cypermethrin results in decreased expression of HMOX1 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA; Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of HMOX1 mRNA]; Sesame Oil affects the reaction [cypermethrin affects the expression of HMOX1]		 CTD PMID:23900960 PMID:25816392 PMID:31907151 PMID:33396045 NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079 		JBrowse link
G Hoxa10 homeobox A10 decreases expression ISO cypermethrin results in decreased expression of HOXA10 mRNA; cypermethrin results in decreased expression of HOXA10 protein CTD PMID:29253587
G Hp1bp3 heterochromatin protein 1, binding protein 3 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000 		JBrowse link
G Hpdl 4-hydroxyphenylpyruvate dioxygenase-like increases expression ISO cypermethrin results in increased expression of HPDL mRNA CTD PMID:29020013 NCBI chr 5:130,286,627...130,288,233
Ensembl chr 5:130,286,631...130,288,233 		JBrowse link
G Hrk harakiri, BCL2 interacting protein decreases expression ISO cypermethrin results in decreased expression of HRK mRNA CTD PMID:29020013 NCBI chr12:38,387,484...38,409,652 JBrowse link
G Hsd17b3 hydroxysteroid (17-beta) dehydrogenase 3 decreases expression
multiple interactions		 ISO
EXP		 cypermethrin results in decreased expression of HSD17B3 mRNA; cypermethrin results in decreased expression of HSD17B3 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA		 CTD PMID:24810582 PMID:33051911 PMID:33396045 NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 decreases expression
multiple interactions		 ISO
EXP		 cypermethrin results in decreased expression of HSD3B1 mRNA; cypermethrin results in decreased expression of HSD3B1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA		 CTD PMID:24810582 PMID:33051911 PMID:33396045 NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999 		JBrowse link
G Hsf2 heat shock transcription factor 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174 		JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 decreases expression ISO cypermethrin results in decreased expression of HSPA5 mRNA CTD PMID:25424538 NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891 		JBrowse link
G Hspbap1 HSPB1 associated protein 1 increases expression ISO cypermethrin results in increased expression of HSPBAP1 mRNA CTD PMID:27704156 NCBI chr11:64,940,089...64,994,753
Ensembl chr11:64,940,091...64,994,756 		JBrowse link
G Hspd1 heat shock protein family D (Hsp60) member 1 increases expression
multiple interactions		 EXP cypermethrin results in increased expression of HSPD1 protein
Minocycline inhibits the reaction [cypermethrin results in increased expression of HSPD1 protein]		 CTD PMID:21561882 NCBI chr 9:56,579,195...56,590,011
Ensembl chr 9:56,579,201...56,589,662 		JBrowse link
G Htr2a 5-hydroxytryptamine receptor 2A multiple interactions
increases expression		 EXP cypermethrin promotes the reaction [cypermethrin results in increased expression of HTR2A mRNA]; cypermethrin promotes the reaction [cypermethrin results in increased expression of HTR2A protein]
cypermethrin results in increased expression of HTR2A mRNA; cypermethrin results in increased expression of HTR2A protein		 CTD PMID:25288152 NCBI chr15:49,950,035...50,022,188
Ensembl chr15:49,950,804...50,020,928 		JBrowse link
G Htt huntingtin increases expression ISO cypermethrin results in increased expression of HTT mRNA CTD PMID:27704156 NCBI chr14:75,845,836...75,996,094
Ensembl chr14:75,845,836...75,995,070 		JBrowse link
G Idh3a isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha decreases expression EXP cypermethrin results in decreased expression of IDH3A protein CTD PMID:21561882 NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084 		JBrowse link
G Ifitm3 interferon induced transmembrane protein 3 increases expression ISO cypermethrin results in increased expression of IFITM3 mRNA CTD PMID:29020013 NCBI chr 1:196,111,026...196,112,135
Ensembl chr 1:196,111,043...196,112,203 		JBrowse link
G Ifng interferon gamma decreases expression EXP cypermethrin results in decreased expression of IFNG mRNA CTD PMID:22528246 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375 		JBrowse link
G Igf1 insulin-like growth factor 1 decreases expression EXP cypermethrin results in decreased expression of IGF1 mRNA CTD PMID:22528246 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor increases expression ISO cypermethrin results in increased expression of IGF1R mRNA CTD PMID:27704156 NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777 		JBrowse link
G Il10 interleukin 10 increases expression EXP cypermethrin results in increased expression of IL10 mRNA CTD PMID:22528246 NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313 		JBrowse link
G Il11 interleukin 11 increases expression EXP cypermethrin results in increased expression of IL11 mRNA CTD PMID:22528246 NCBI chr 1:69,069,829...69,076,129
Ensembl chr 1:69,068,137...69,076,129 		JBrowse link
G Il1b interleukin 1 beta increases expression
multiple interactions		 EXP
ISO		 cypermethrin results in increased expression of IL1B mRNA; cypermethrin results in increased expression of IL1B protein
cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of IL1B protein]		 CTD PMID:22528246 PMID:23900960 PMID:29471534 NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415 		JBrowse link
G Il6 interleukin 6 affects expression
multiple interactions		 EXP cypermethrin affects the expression of IL6
Sesame Oil affects the reaction [cypermethrin affects the expression of IL6]		 CTD PMID:25816392 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178 		JBrowse link
G Il9 interleukin 9 increases expression EXP cypermethrin results in increased expression of IL9 mRNA CTD PMID:22528246 NCBI chr17:8,111,772...8,114,895
Ensembl chr17:8,111,772...8,114,895 		JBrowse link
G Il9r interleukin 9 receptor increases expression EXP cypermethrin results in increased expression of IL9R mRNA CTD PMID:22528246 NCBI chr10:15,431,706...15,444,144
Ensembl chr10:15,431,706...15,441,990 		JBrowse link
G Ilk integrin-linked kinase decreases expression EXP cypermethrin results in decreased expression of ILK mRNA CTD PMID:22528246 NCBI chr 1:160,088,839...160,095,140
Ensembl chr 1:160,088,897...160,095,140 		JBrowse link
G Ina internexin neuronal intermediate filament protein, alpha increases expression
multiple interactions		 EXP cypermethrin results in increased expression of INA protein
Minocycline inhibits the reaction [cypermethrin results in increased expression of INA protein]		 CTD PMID:21561882 NCBI chr 1:245,896,775...245,908,330
Ensembl chr 1:245,896,775...245,908,330 		JBrowse link
G Inhba inhibin subunit beta A multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of INHBA mRNA CTD PMID:33051911 PMID:33396045 NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982 		JBrowse link
G Inhbb inhibin subunit beta B multiple interactions
decreases expression		 EXP
ISO		 [cypermethrin co-treated with Diethylhexyl Phthalate] results in decreased expression of INHBB mRNA
cypermethrin results in decreased expression of INHBB protein
cypermethrin results in decreased expression of INHBB mRNA; cypermethrin results in decreased expression of INHBB protein		 CTD PMID:24641848 PMID:30974244 NCBI chr13:30,530,860...30,536,566
Ensembl chr13:30,530,860...30,537,832 		JBrowse link
G Insl3 insulin-like 3 decreases expression ISO cypermethrin results in decreased expression of INSL3 mRNA CTD PMID:24810582 NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560 		JBrowse link
G Iqub IQ motif and ubiquitin domain containing increases expression ISO cypermethrin results in increased expression of IQUB mRNA CTD PMID:29020013 NCBI chr 4:52,931,768...52,993,795
Ensembl chr 4:52,931,767...52,993,834 		JBrowse link
G Irs2 insulin receptor substrate 2 decreases expression EXP cypermethrin results in decreased expression of IRS2 mRNA CTD PMID:22528246 NCBI chr16:78,488,249...78,512,482
Ensembl chr16:78,485,045...78,512,482 		JBrowse link
G Itgae integrin subunit alpha E decreases expression EXP cypermethrin results in decreased expression of ITGAE mRNA CTD PMID:22528246 NCBI chr10:57,704,813...57,764,093
Ensembl chr10:57,591,753...57,764,093 		JBrowse link
G Itgam integrin subunit alpha M multiple interactions ISO Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of ITGAM mRNA] CTD PMID:29945211 NCBI chr 1:182,659,047...182,709,495
Ensembl chr 1:182,659,000...182,709,503 		JBrowse link
G Itgb3 integrin subunit beta 3 increases expression EXP cypermethrin results in increased expression of ITGB3 mRNA CTD PMID:22528246 NCBI chr10:89,509,917...89,564,679
Ensembl chr10:89,509,989...89,564,679 		JBrowse link
G Itgb6 integrin subunit beta 6 increases expression EXP cypermethrin results in increased expression of ITGB6 mRNA CTD PMID:22528246 NCBI chr 3:45,046,295...45,170,532
Ensembl chr 3:45,048,044...45,121,671 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor, type 1 decreases expression EXP cypermethrin results in decreased expression of ITPR1 mRNA CTD PMID:22528246 NCBI chr 4:141,187,377...141,554,240
Ensembl chr 4:141,187,418...141,510,491 		JBrowse link
G Jph3 junctophilin 3 increases expression ISO cypermethrin results in increased expression of JPH3 mRNA CTD PMID:27704156 NCBI chr19:49,793,967...49,855,338
Ensembl chr19:49,793,092...49,855,338 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions		 EXP
ISO		 cypermethrin results in increased expression of JUN protein
cypermethrin results in increased expression of JUN mRNA; cypermethrin results in increased expression of JUN protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of JUN protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of JUN protein]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of JUN protein]		 CTD PMID:8856738 PMID:29149324 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656 		JBrowse link
G Jup junction plakoglobin decreases expression EXP cypermethrin results in decreased expression of JUP mRNA CTD PMID:22528246 NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057 		JBrowse link
G Kcnj9 potassium inwardly-rectifying channel, subfamily J, member 9 decreases expression EXP cypermethrin results in decreased expression of KCNJ9 mRNA CTD PMID:22528246 NCBI chr13:84,780,826...84,787,928
Ensembl chr13:84,779,741...84,787,928 		JBrowse link
G Kdr kinase insert domain receptor increases expression ISO cypermethrin results in increased expression of KDR mRNA CTD PMID:29020013 NCBI chr14:32,217,871...32,261,018
Ensembl chr14:32,217,871...32,261,018 		JBrowse link
G Kif9 kinesin family member 9 increases expression ISO cypermethrin results in increased expression of KIF9 mRNA CTD PMID:21142847 NCBI chr 8:110,459,467...110,504,492
Ensembl chr 8:110,459,383...110,505,252 		JBrowse link
G Kitlg KIT ligand multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214 		JBrowse link
G Klf2 Kruppel-like factor 2 decreases expression ISO cypermethrin results in decreased expression of KLF2 mRNA CTD PMID:25424538 NCBI chr16:17,521,773...17,523,723
Ensembl chr16:17,514,552...17,523,944 		JBrowse link
G Klf4 Kruppel like factor 4 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA CTD PMID:33396045 NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602 		JBrowse link
G Kti12 KTI12 chromatin associated increases expression ISO cypermethrin results in increased expression of KTI12 mRNA CTD PMID:29020013 NCBI chr 5:123,601,059...123,602,581
Ensembl chr 5:123,599,436...123,613,964 		JBrowse link
G Kyat1 kynurenine aminotransferase 1 decreases activity ISO cypermethrin results in decreased activity of KYAT1 protein CTD PMID:7175100 NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355 		JBrowse link
G Kynu kynureninase decreases activity ISO cypermethrin results in decreased activity of KYNU protein CTD PMID:7175100 NCBI chr 3:27,778,646...27,929,470
Ensembl chr 3:27,778,772...27,929,488 		JBrowse link
G Lgals7 galectin 7 decreases expression EXP cypermethrin results in decreased expression of LGALS7 mRNA CTD PMID:22528246 NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015 		JBrowse link
G Lhb luteinizing hormone subunit beta increases expression
increases secretion
multiple interactions
decreases expression		 EXP
ISO		 cypermethrin results in increased expression of LHB protein
cypermethrin results in increased secretion of LHB protein
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased secretion of LHB protein]; 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; cypermethrin inhibits the reaction [cetrorelix results in decreased secretion of LHB protein]; cypermethrin results in increased expression of and results in increased secretion of LHB protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased secretion of LHB protein]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of LHB mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased secretion of LHB protein]
Vitamin E inhibits the reaction [cypermethrin results in decreased expression of LHB protein]		 CTD PMID:23447098 PMID:24759048 PMID:28731686 PMID:29149324 NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Lhcgr luteinizing hormone/choriogonadotropin receptor multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of LHCGR mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521 		JBrowse link
G LOC102546572 zinc finger protein 709-like increases expression ISO cypermethrin results in increased expression of ZFP617 mRNA CTD PMID:29020013 NCBI chr 7:11,846,077...11,868,732
Ensembl chr 7:11,845,560...11,868,717 		JBrowse link
G LOC102548682 histone H4-like decreases expression ISO cypermethrin results in decreased expression of H4C14 mRNA CTD PMID:29020013 NCBI chr17:41,368,743...41,426,735 JBrowse link
G Lpp LIM domain containing preferred translocation partner in lipoma increases expression ISO cypermethrin results in increased expression of LPP mRNA CTD PMID:29020013 NCBI chr11:75,787,326...76,426,646
Ensembl chr11:75,797,078...76,422,597 		JBrowse link
G Ltb4r2 leukotriene B4 receptor 2 decreases expression ISO cypermethrin results in decreased expression of LTB4R2 mRNA CTD PMID:29020013 NCBI chr15:29,258,427...29,260,340
Ensembl chr15:29,259,240...29,260,316 		JBrowse link
G Lysmd2 LysM domain containing 2 increases expression ISO cypermethrin results in increased expression of LYSMD2 mRNA CTD PMID:29020013 NCBI chr 8:76,378,984...76,394,395
Ensembl chr 8:76,379,219...76,394,654 		JBrowse link
G Maoa monoamine oxidase A decreases activity
multiple interactions
decreases expression		 EXP cypermethrin results in decreased activity of MAOA protein
Chlorpyrifos promotes the reaction [cypermethrin results in decreased activity of MAOA protein]; Chlorpyrifos promotes the reaction [cypermethrin results in decreased expression of MAOA mRNA]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased activity of MAOA protein]; cypermethrin promotes the reaction [Chlorpyrifos results in decreased expression of MAOA mRNA]		 CTD PMID:8385837 PMID:32006337 NCBI chr  X:6,032,172...6,098,308
Ensembl chr  X:6,030,795...6,099,593 		JBrowse link
G Map1lc3a microtubule-associated protein 1 light chain 3 alpha increases expression ISO cypermethrin results in increased expression of MAP1LC3A mRNA CTD PMID:27704156 NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670 		JBrowse link
G Map2 microtubule-associated protein 2 decreases expression EXP cypermethrin results in decreased expression of MAP2 mRNA CTD PMID:22528246 NCBI chr 9:67,723,422...67,981,886
Ensembl chr 9:67,723,371...67,979,809 		JBrowse link
G Map2k4 mitogen activated protein kinase kinase 4 multiple interactions ISO [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein; [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; [[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein CTD PMID:29471534 NCBI chr10:50,343,227...50,447,956
Ensembl chr10:50,344,915...50,447,993 		JBrowse link
G Map3k4 mitogen activated protein kinase kinase kinase 4 increases expression EXP cypermethrin results in increased expression of MAP3K4 mRNA CTD PMID:22528246 NCBI chr 1:48,431,801...48,519,358
Ensembl chr 1:48,431,830...48,519,358 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of MAPK1 protein; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK1 protein]; cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Nimodipine inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein]; Thapsigargin inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK1 protein] CTD PMID:29149324 PMID:30974244 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616 		JBrowse link
G Mapk10 mitogen activated protein kinase 10 increases expression ISO cypermethrin results in increased expression of MAPK10 mRNA CTD PMID:29020013 NCBI chr14:6,497,662...6,790,109
Ensembl chr14:6,497,707...6,786,201 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of MAPK3 protein; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased phosphorylation of MAPK3 protein]; cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Nimodipine inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; Thapsigargin inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein]; W 7 inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of MAPK3 protein] CTD PMID:29149324 PMID:30974244 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863 		JBrowse link
G Mapk4 mitogen-activated protein kinase 4 decreases expression EXP cypermethrin results in decreased expression of MAPK4 mRNA CTD PMID:22528246 NCBI chr18:67,512,805...67,661,271
Ensembl chr18:67,512,807...67,661,842 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 increases expression
multiple interactions		 ISO cypermethrin results in increased expression of MAPK8 mRNA
[[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein		 CTD PMID:27704156 PMID:29471534 NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981 		JBrowse link
G Mapk9 mitogen-activated protein kinase 9 multiple interactions ISO [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein CTD PMID:29471534 NCBI chr10:34,169,661...34,211,138
Ensembl chr10:34,169,675...34,210,178 		JBrowse link
G Mapkapk5 MAPK activated protein kinase 5 multiple interactions EXP Minocycline inhibits the reaction [cypermethrin results in increased expression of MAPKAPK5 protein] CTD PMID:21561882 NCBI chr12:34,993,520...35,013,059
Ensembl chr12:34,994,092...35,013,052 		JBrowse link
G Mapt microtubule-associated protein tau decreases expression
increases expression		 EXP
ISO		 cypermethrin results in decreased expression of MAPT mRNA
cypermethrin results in increased expression of MAPT protein		 CTD PMID:22528246 PMID:26143737 NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129 		JBrowse link
G Mb myoglobin increases expression ISO cypermethrin results in increased expression of MB mRNA CTD PMID:21142847 NCBI chr 7:108,759,903...108,767,134
Ensembl chr 7:108,759,904...108,767,383 		JBrowse link
G Mbd4 methyl-CpG binding domain 4 DNA glycosylase increases expression ISO cypermethrin results in increased expression of MBD4 mRNA CTD PMID:21142847 NCBI chr 4:148,893,049...148,904,833
Ensembl chr 4:148,894,280...148,904,982 		JBrowse link
G Mertk MER proto-oncogene, tyrosine kinase affects expression ISO cypermethrin affects the expression of MERTK mRNA CTD PMID:29020013 NCBI chr 3:115,939,351...116,045,141
Ensembl chr 3:115,939,351...116,046,554 		JBrowse link
G Mgmt O-6-methylguanine-DNA methyltransferase increases expression ISO cypermethrin results in increased expression of MGMT mRNA CTD PMID:21142847 NCBI chr 1:191,710,980...191,937,760
Ensembl chr 1:191,710,930...191,937,756 		JBrowse link
G Mir155 microRNA 155 decreases expression
multiple interactions		 ISO cypermethrin results in decreased expression of MIR155 mRNA
[[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK8 protein; [[[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein] which results in decreased phosphorylation of and results in decreased activity of MAPK9 protein; [[cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA] which results in decreased expression of MAP2K4 protein; [cypermethrin results in decreased expression of MIR155 mRNA] which results in increased expression of BCL6 mRNA		 CTD PMID:29471534 NCBI chr11:23,774,654...23,774,718
Ensembl chr11:23,774,654...23,774,718 		JBrowse link
G Mlh1 mutL homolog 1 increases expression ISO cypermethrin results in increased expression of MLH1 mRNA CTD PMID:21142847 NCBI chr 8:111,196,468...111,233,721
Ensembl chr 8:111,196,468...111,233,617 		JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions
decreases expression		 ISO cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP10 mRNA]
cypermethrin results in decreased expression of MMP10 mRNA		 CTD PMID:29020013 PMID:29471534 NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions ISO cypermethrin promotes the reaction [Lipopolysaccharides results in increased expression of MMP9 mRNA] CTD PMID:29471534 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120 		JBrowse link
G Mpo myeloperoxidase increases expression ISO cypermethrin results in increased expression of MPO mRNA CTD PMID:21142847 NCBI chr10:72,594,458...72,608,862
Ensembl chr10:72,594,661...72,604,819 		JBrowse link
G Mpp4 MAGUK p55 scaffold protein 4 increases expression ISO cypermethrin results in increased expression of MPP4 mRNA CTD PMID:21142847 NCBI chr 9:60,569,734...60,613,035
Ensembl chr 9:60,569,734...60,611,797 		JBrowse link
G Mrpl14 mitochondrial ribosomal protein L14 decreases expression ISO cypermethrin results in decreased expression of MRPL14 mRNA CTD PMID:29020013 NCBI chr 9:15,302,840...15,315,195
Ensembl chr 9:15,302,427...15,315,267 		JBrowse link
G Mt2A metallothionein 2A increases expression
decreases expression		 ISO cypermethrin results in increased expression of MT2 mRNA
cypermethrin results in decreased expression of MT2 mRNA		 CTD PMID:21142847 PMID:29020013 NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784 		JBrowse link
G Nanog Nanog homeobox increases expression ISO cypermethrin results in increased expression of NANOG mRNA CTD PMID:32214279 NCBI chr 4:155,943,737...155,951,116
Ensembl chr 4:155,943,737...155,951,116 		JBrowse link
G Nanos3 nanos C2HC-type zinc finger 3 decreases expression ISO cypermethrin results in decreased expression of NANOS3 mRNA CTD PMID:24810582 NCBI chr19:23,978,465...23,988,933
Ensembl chr19:23,985,504...23,988,932 		JBrowse link
G Nanp N-acetylneuraminic acid phosphatase decreases expression ISO cypermethrin results in decreased expression of NANP mRNA CTD PMID:29020013 NCBI chr 3:139,826,549...139,841,655
Ensembl chr 3:139,826,549...139,841,648 		JBrowse link
G Ncam1 neural cell adhesion molecule 1 decreases expression EXP cypermethrin results in decreased expression of NCAM1 mRNA CTD PMID:22528246 NCBI chr 8:49,865,629...50,165,687
Ensembl chr 8:49,865,633...50,166,014 		JBrowse link
G Ncf2 neutrophil cytosolic factor 2 increases expression ISO cypermethrin results in increased expression of NCF2 mRNA CTD PMID:21142847 NCBI chr13:64,955,502...64,986,289
Ensembl chr13:64,955,503...64,986,277 		JBrowse link
G Ncoa7 nuclear receptor coactivator 7 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NCOA7 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NCOA7 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871 		JBrowse link
G Ndufv2 NADH:ubiquinone oxidoreductase core subunit V2 decreases expression EXP cypermethrin results in decreased expression of NDUFV2 protein CTD PMID:21561882 NCBI chr 9:105,690,454...105,710,669
Ensembl chr 9:105,690,455...105,710,713 		JBrowse link
G Neb nebulin decreases expression EXP cypermethrin results in decreased expression of NEB mRNA CTD PMID:22528246 NCBI chr 3:36,613,677...36,811,618
Ensembl chr 3:36,613,716...36,811,574 		JBrowse link
G Nefh neurofilament heavy chain increases expression ISO cypermethrin results in increased expression of NEFH mRNA CTD PMID:32028016 NCBI chr14:79,830,362...79,840,347
Ensembl chr14:79,830,362...79,840,351 		JBrowse link
G Nefl neurofilament light chain decreases expression ISO cypermethrin results in decreased expression of NEFL mRNA CTD PMID:32028016 NCBI chr15:42,301,920...42,305,793
Ensembl chr15:42,301,916...42,305,793 		JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression
multiple interactions
decreases expression		 ISO
EXP		 cypermethrin results in increased expression of NFE2L2 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA
cypermethrin results in decreased expression of NFE2L2 mRNA; cypermethrin results in decreased expression of NFE2L2 protein		 CTD PMID:31907151 PMID:32028016 PMID:33396045 NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737 		JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 increases expression ISO cypermethrin results in increased expression of NFKB1 mRNA CTD PMID:27704156 NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404 		JBrowse link
G Ngb neuroglobin increases expression ISO cypermethrin results in increased expression of NGB mRNA CTD PMID:21142847 NCBI chr 6:106,744,378...106,749,830
Ensembl chr 6:106,744,378...106,749,830 		JBrowse link
G Nhsl1 NHS-like 1 increases expression ISO cypermethrin results in increased expression of NHSL1 mRNA CTD PMID:29020013 NCBI chr 1:12,956,525...13,188,580
Ensembl chr 1:12,956,021...13,187,547 		JBrowse link
G Nol3 nucleolar protein 3 increases expression ISO cypermethrin results in increased expression of NOL3 mRNA CTD PMID:27704156 NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression		 EXP
ISO		 Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of NOS2 mRNA]
cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
cypermethrin results in increased expression of NOS2 mRNA; cypermethrin results in increased expression of NOS2 protein		 CTD PMID:22528246 PMID:23900960 PMID:29471534 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210 		JBrowse link
G Nox4 NADPH oxidase 4 increases expression ISO cypermethrin results in increased expression of NOX4 mRNA CTD PMID:21142847 NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
decreases expression		 ISO
EXP		 cypermethrin results in increased expression of NQO1; cypermethrin results in increased expression of NQO1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NQO1 mRNA
cypermethrin results in decreased expression of NQO1 mRNA; cypermethrin results in decreased expression of NQO1 protein		 CTD PMID:31907151 PMID:32214279 PMID:33396045 NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557 		JBrowse link
G Nr0b1 nuclear receptor subfamily 0, group B, member 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NR0B1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr  X:50,756,886...50,761,014
Ensembl chr  X:50,756,886...50,761,011 		JBrowse link
G Nr1d1 nuclear receptor subfamily 1, group D, member 1 decreases expression ISO cypermethrin results in decreased expression of NR1D1 mRNA CTD PMID:29020013 NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705 		JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 multiple interactions ISO cypermethrin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] CTD PMID:25257666 NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions
increases activity
increases expression		 ISO
EXP		 cypermethrin binds to and results in increased activity of NR1I2 protein
cypermethrin results in increased activity of NR1I2 protein
cypermethrin results in increased expression of NR1I2 mRNA		 CTD PMID:15548381 PMID:16054614 PMID:21115097 PMID:22206814 PMID:22310298 More... NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Nr1i3 nuclear receptor subfamily 1, group I, member 3 multiple interactions
increases expression		 ISO cypermethrin binds to and results in increased activity of NR1I3 protein; cypermethrin inhibits the reaction [Androstane-3,17-diol binds to and results in decreased activity of NR1I3 protein]
cypermethrin results in increased expression of NR1I3 mRNA		 CTD PMID:16929008 PMID:18832183 PMID:22310298 NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO cypermethrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] CTD PMID:26647222 NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375 		JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 multiple interactions ISO cypermethrin inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; cypermethrin inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] CTD PMID:29149346 NCBI chr19:30,715,648...31,059,885
Ensembl chr19:30,715,648...31,059,885 		JBrowse link
G Nr5a1 nuclear receptor subfamily 5, group A, member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NR5A1 mRNA CTD PMID:33396045 NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328 		JBrowse link
G Nrarp Notch-regulated ankyrin repeat protein increases expression ISO cypermethrin results in increased expression of NRARP mRNA CTD PMID:29020013 NCBI chr 3:7,992,582...7,995,136
Ensembl chr 3:7,992,552...7,995,133 		JBrowse link
G Ntrk2 neurotrophic receptor tyrosine kinase 2 decreases expression EXP cypermethrin results in decreased expression of NTRK2 mRNA CTD PMID:22528246 NCBI chr17:5,558,992...5,870,299
Ensembl chr17:5,559,043...5,869,136 		JBrowse link
G Nudt15 nudix hydrolase 15 increases expression ISO cypermethrin results in increased expression of NUDT15 mRNA CTD PMID:21142847 NCBI chr15:48,707,776...48,747,363
Ensembl chr15:48,709,700...48,747,363 		JBrowse link
G Nudt18 nudix hydrolase 18 decreases expression ISO cypermethrin results in decreased expression of NUDT18 mRNA CTD PMID:29020013 NCBI chr15:45,650,597...45,653,985
Ensembl chr15:45,650,664...45,653,963 		JBrowse link
G Nxph4 neurexophilin 4 increases expression ISO cypermethrin results in increased expression of NXPH4 mRNA CTD PMID:29020013 NCBI chr 7:63,367,758...63,376,579
Ensembl chr 7:63,367,761...63,376,579 		JBrowse link
G Olr1073 olfactory receptor 1073 increases expression ISO cypermethrin results in increased expression of OLFR1351 mRNA CTD PMID:29020013 NCBI chr 7:10,489,998...10,490,933
Ensembl chr 7:10,487,925...10,492,031 		JBrowse link
G Olr159 olfactory receptor 159 increases expression ISO cypermethrin results in increased expression of OLFR666 mRNA CTD PMID:29020013 NCBI chr 1:158,919,013...158,919,978
Ensembl chr 1:158,916,975...158,920,576 		JBrowse link
G Olr1596 olfactory receptor 1596 decreases expression ISO cypermethrin results in decreased expression of OLFR420 mRNA CTD PMID:29020013 NCBI chr13:86,186,442...86,190,391
Ensembl chr13:86,185,529...86,190,815 		JBrowse link
G Olr604 olfactory receptor 604 decreases expression ISO cypermethrin results in decreased expression of OLFR1155 mRNA CTD PMID:29020013 NCBI chr 3:73,465,350...73,466,307
Ensembl chr 3:73,465,350...73,466,307 		JBrowse link
G Olr813 olfactory receptor 813 decreases expression ISO cypermethrin results in decreased expression of OLFR447 mRNA CTD PMID:29020013 NCBI chr 4:71,878,578...71,879,519
Ensembl chr 4:71,878,578...71,879,519 		JBrowse link
G Otub2 OTU deubiquitinase, ubiquitin aldehyde binding 2 increases expression ISO cypermethrin results in increased expression of OTUB2 mRNA CTD PMID:29020013 NCBI chr 6:122,545,029...122,563,651
Ensembl chr 6:122,545,061...122,563,644 		JBrowse link
G Ovol1 ovo like transcriptional repressor 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OVOL1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831 		JBrowse link
G P4htm prolyl 4-hydroxylase, transmembrane increases expression ISO cypermethrin results in increased expression of P4HTM mRNA CTD PMID:32573024 NCBI chr 8:109,274,629...109,292,802
Ensembl chr 8:109,274,626...109,292,473 		JBrowse link
G Pafah1b2 platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 decreases expression
multiple interactions		 EXP cypermethrin results in decreased expression of PAFAH1B2 protein
Minocycline inhibits the reaction [cypermethrin results in decreased expression of PAFAH1B2 protein]		 CTD PMID:21561882 NCBI chr 8:46,260,069...46,312,073
Ensembl chr 8:46,261,064...46,279,833 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions
decreases expression		 ISO cypermethrin inhibits the reaction [Docosahexaenoic Acids results in increased degradation of PARP1 protein]
cypermethrin results in decreased expression of PARP1 mRNA		 CTD PMID:11341974 PMID:27704156 NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404 		JBrowse link
G Parp2 poly (ADP-ribose) polymerase 2 increases expression ISO cypermethrin results in increased expression of PARP2 mRNA CTD PMID:27704156 NCBI chr15:24,034,069...24,044,340
Ensembl chr15:24,034,106...24,044,338 		JBrowse link
G Pbk PDZ binding kinase increases expression ISO cypermethrin results in increased expression of PBK mRNA CTD PMID:29020013 NCBI chr15:40,022,873...40,034,014
Ensembl chr15:40,023,002...40,034,014 		JBrowse link
G Pcna proliferating cell nuclear antigen affects expression
multiple interactions
decreases expression		 ISO
EXP		 cypermethrin affects the expression of PCNA mRNA; cypermethrin affects the expression of PCNA protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PCNA mRNA
cypermethrin results in decreased expression of PCNA mRNA; cypermethrin results in decreased expression of PCNA protein		 CTD PMID:24810582 PMID:33051911 PMID:33396045 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995 		JBrowse link
G Pde4b phosphodiesterase 4B multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696 		JBrowse link
G Pdgfa platelet derived growth factor subunit A increases expression EXP cypermethrin results in increased expression of PDGFA mRNA CTD PMID:22528246 NCBI chr12:15,645,549...15,667,056
Ensembl chr12:15,645,541...15,666,497 		JBrowse link
G Pdia3 protein disulfide isomerase family A, member 3 decreases expression EXP cypermethrin results in decreased expression of PDIA3 protein CTD PMID:21561882 NCBI chr 3:108,388,189...108,412,013
Ensembl chr 3:108,388,245...108,413,236 		JBrowse link
G Pebp1 phosphatidylethanolamine binding protein 1 increases expression EXP cypermethrin results in increased expression of PEBP1 protein CTD PMID:21561882 NCBI chr12:39,302,864...39,307,064
Ensembl chr12:39,302,840...39,307,862 		JBrowse link
G Pgr progesterone receptor increases expression
affects binding		 ISO cypermethrin results in increased expression of PGR mRNA; cypermethrin results in increased expression of PGR protein
cypermethrin binds to PGR protein		 CTD PMID:29253587 PMID:32278787 NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344 		JBrowse link
G Phb1 prohibitin 1 decreases expression EXP cypermethrin results in decreased expression of PHB1 protein CTD PMID:21561882 NCBI chr10:80,605,268...80,618,043
Ensembl chr10:80,605,251...80,618,042 		JBrowse link
G Pik3c3 phosphatidylinositol 3-kinase, catalytic subunit type 3 increases expression ISO cypermethrin results in increased expression of PIK3C3 mRNA CTD PMID:32028016 NCBI chr18:21,845,282...21,934,387
Ensembl chr18:21,845,295...21,929,048 		JBrowse link
G Pinx1 PIN2/TERF1 interacting, telomerase inhibitor 1 increases expression ISO cypermethrin results in increased expression of PINX1 mRNA CTD PMID:21142847 NCBI chr15:38,098,027...38,157,143
Ensembl chr15:38,097,886...38,157,140 		JBrowse link
G Pklr pyruvate kinase L/R multiple interactions ISO [lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of PKLR mRNA CTD PMID:24440342 NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870 		JBrowse link
G Plekhf1 pleckstrin homology and FYVE domain containing 1 decreases expression ISO cypermethrin results in decreased expression of PLEKHF1 mRNA CTD PMID:29020013 NCBI chr 1:90,908,304...90,915,862
Ensembl chr 1:90,904,742...90,915,820 		JBrowse link
G Pmch pro-melanin-concentrating hormone decreases expression ISO cypermethrin results in decreased expression of PMCH mRNA CTD PMID:29020013 NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:22,511,934...22,513,250 		JBrowse link
G Pms1 PMS1 homolog 1, mismatch repair system component increases expression ISO cypermethrin results in increased expression of PMS1 mRNA CTD PMID:21142847 NCBI chr 9:48,229,403...48,340,237
Ensembl chr 9:48,253,410...48,340,237 		JBrowse link
G Pold3 DNA polymerase delta 3, accessory subunit increases expression ISO cypermethrin results in increased expression of POLD3 mRNA CTD PMID:21142847 NCBI chr 1:154,417,893...154,456,687
Ensembl chr 1:154,418,084...154,456,665 		JBrowse link
G Polh DNA polymerase eta increases expression ISO cypermethrin results in increased expression of POLH mRNA CTD PMID:21142847 NCBI chr 9:14,778,355...14,813,210
Ensembl chr 9:14,777,888...14,812,723 		JBrowse link
G Poli DNA polymerase iota increases expression ISO cypermethrin results in increased expression of POLI mRNA CTD PMID:21142847 NCBI chr18:64,116,774...64,134,373
Ensembl chr18:64,116,774...64,163,418 		JBrowse link
G Pou5f1 POU class 5 homeobox 1 increases expression ISO cypermethrin results in increased expression of POU5F1 mRNA CTD PMID:32214279 NCBI chr20:3,223,128...3,227,891
Ensembl chr20:3,223,129...3,227,891 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARA mRNA] CTD PMID:24440342 NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO cypermethrin binds to and results in increased activity of PPARG protein CTD PMID:33049310 NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468 		JBrowse link
G Ppp1r15b protein phosphatase 1, regulatory subunit 15B increases expression ISO cypermethrin results in increased expression of PPP1R15B mRNA CTD PMID:21142847 NCBI chr13:44,577,840...44,585,737
Ensembl chr13:44,577,932...44,585,737 		JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha multiple interactions ISO [cypermethrin results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin CTD PMID:10898953 NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:225,165,766...225,438,974 		JBrowse link
G Ppt1 palmitoyl-protein thioesterase 1 decreases expression ISO cypermethrin results in decreased expression of PPT1 mRNA CTD PMID:29020013 NCBI chr 5:135,121,176...135,141,076
Ensembl chr 5:135,121,163...135,142,048 		JBrowse link
G Prdx2 peroxiredoxin 2 increases expression ISO cypermethrin results in increased expression of PRDX2 mRNA CTD PMID:21142847 NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194 		JBrowse link
G Prdx4 peroxiredoxin 4 increases expression ISO cypermethrin results in increased expression of PRDX4 mRNA CTD PMID:21142847 NCBI chr  X:40,026,762...40,044,066
Ensembl chr  X:40,026,651...40,044,066 		JBrowse link
G Prdx5 peroxiredoxin 5 increases expression ISO cypermethrin results in increased expression of PRDX5 mRNA CTD PMID:21142847 NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268 		JBrowse link
G Prm1 protamine 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr10:4,871,909...4,872,155 JBrowse link
G Prm2 protamine 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM2 mRNA CTD PMID:33396045 NCBI chr10:4,876,398...4,876,834
Ensembl chr10:4,873,372...4,877,026 		JBrowse link
G Prxl2a peroxiredoxin like 2A decreases expression ISO cypermethrin results in decreased expression of PRXL2A mRNA CTD PMID:29020013 NCBI chr16:16,866,601...16,886,378
Ensembl chr16:16,866,603...16,886,433 		JBrowse link
G Psen1 presenilin 1 increases expression EXP cypermethrin results in increased expression of PSEN1 mRNA CTD PMID:22528246 NCBI chr 6:103,323,014...103,375,088
Ensembl chr 6:103,323,120...103,371,650 		JBrowse link
G Psmb5 proteasome 20S subunit beta 5 increases expression ISO cypermethrin results in increased expression of PSMB5 mRNA CTD PMID:21142847 NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [cypermethrin binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 CTD PMID:26359731 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Pygo2 pygopus family PHD finger 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PYGO2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PYGO2 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 2:174,849,670...174,854,758
Ensembl chr 2:174,849,936...174,854,758 		JBrowse link
G Rad51 RAD51 recombinase increases expression ISO cypermethrin results in increased expression of RAD51 mRNA CTD PMID:21142847 NCBI chr 3:106,099,753...106,125,038
Ensembl chr 3:106,100,381...106,125,035 		JBrowse link
G Rad51b RAD51 paralog B increases expression ISO cypermethrin results in increased expression of RAD51B mRNA CTD PMID:21142847 NCBI chr 6:98,096,525...98,640,988
Ensembl chr 6:98,098,868...98,640,979 		JBrowse link
G Rad51c RAD51 paralog C increases expression ISO cypermethrin results in increased expression of RAD51C mRNA CTD PMID:21142847 NCBI chr10:72,205,032...72,231,643
Ensembl chr10:72,205,032...72,231,248 		JBrowse link
G Raf1 Raf-1 proto-oncogene, serine/threonine kinase multiple interactions ISO 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; bisindolylmaleimide I inhibits the reaction [cypermethrin results in increased phosphorylation of RAF1 protein]; cypermethrin promotes the reaction [[Hydrogen Peroxide co-treated with Tetradecanoylphorbol Acetate] results in increased activity of RAF1 protein]; cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein; Egtazic Acid inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; Nimodipine inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; Thapsigargin inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein]; W 7 inhibits the reaction [cypermethrin results in increased phosphorylation of and results in increased activity of RAF1 protein] CTD PMID:14623285 PMID:29149324 NCBI chr 4:148,679,534...148,740,265
Ensembl chr 4:148,679,530...148,740,317 		JBrowse link
G Rag2 recombination activating 2 increases expression ISO cypermethrin results in increased expression of RAG2 mRNA CTD PMID:21142847 NCBI chr 3:87,902,373...87,910,227
Ensembl chr 3:87,902,238...87,911,066 		JBrowse link
G Rdh14 retinol dehydrogenase 14 increases expression ISO cypermethrin results in increased expression of RDH14 mRNA CTD PMID:29020013 NCBI chr 6:33,156,569...33,161,712
Ensembl chr 6:33,156,569...33,161,712 		JBrowse link
G Retsat retinol saturase multiple interactions
decreases expression		 ISO Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of RETSAT mRNA] CTD PMID:31659573 NCBI chr 4:104,653,306...104,662,069
Ensembl chr 4:104,653,155...104,668,310 		JBrowse link
G Rpl13 ribosomal protein L13 decreases expression ISO cypermethrin results in decreased expression of RPL13 mRNA CTD PMID:29020013 NCBI chr19:51,153,990...51,156,541
Ensembl chr19:51,153,924...51,163,014 		JBrowse link
G Rpl15 ribosomal protein L15 decreases expression ISO cypermethrin results in decreased expression of RPL15 mRNA CTD PMID:29020013 NCBI chr15:7,503,883...7,507,166
Ensembl chr15:7,503,883...7,507,165 		JBrowse link
G Rpl29 ribosomal protein L29 decreases expression ISO cypermethrin results in decreased expression of RPL29 mRNA CTD PMID:29020013 NCBI chr 8:107,068,929...107,070,963
Ensembl chr 8:107,068,480...107,070,914 		JBrowse link
G Rpl35 ribosomal protein L35 increases expression ISO cypermethrin results in increased expression of RPL35 mRNA CTD PMID:29020013 NCBI chr 3:22,753,255...22,756,217
Ensembl chr 3:22,753,253...22,756,243 		JBrowse link
G Rpl9 ribosomal protein L9 decreases expression ISO cypermethrin results in decreased expression of RPL9 mRNA CTD PMID:29020013 NCBI chr14:42,893,945...42,897,140
Ensembl chr14:42,893,942...42,897,136 		JBrowse link
G Rps18 ribosomal protein S18 decreases expression ISO cypermethrin results in decreased expression of RPS18 mRNA CTD PMID:29020013 NCBI chr20:4,931,427...4,935,538
Ensembl chr10:101,204,500...101,205,146
Ensembl chr20:101,204,500...101,205,146 		JBrowse link
G Rps27a ribosomal protein S27a decreases expression ISO cypermethrin results in decreased expression of RPS27A mRNA CTD PMID:29020013 NCBI chr14:103,285,734...103,288,011
Ensembl chr14:103,285,734...103,288,011 		JBrowse link
G Rps29 ribosomal protein S29 decreases expression EXP cypermethrin results in decreased expression of RPS29 mRNA CTD PMID:22528246 NCBI chr 6:87,635,229...87,636,605
Ensembl chr 6:87,635,230...87,636,636 		JBrowse link
G Rpsa ribosomal protein SA increases expression EXP cypermethrin results in increased expression of RPSA mRNA CTD PMID:22528246 NCBI chr 8:119,851,225...119,855,103
Ensembl chr 8:119,851,225...119,855,247 		JBrowse link
G Scamp2 secretory carrier membrane protein 2 decreases expression EXP cypermethrin results in decreased expression of SCAMP2 mRNA CTD PMID:22528246 NCBI chr 8:57,965,612...57,992,248
Ensembl chr 8:57,965,631...57,992,646 		JBrowse link
G Scarb1 scavenger receptor class B, member 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SCARB1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647 		JBrowse link
G Scd stearoyl-CoA desaturase multiple interactions ISO [lard co-treated with Cholesterol co-treated with Sucrose co-treated with cypermethrin] results in increased expression of SCD1 mRNA CTD PMID:24440342 NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562 		JBrowse link
G Scn10a sodium voltage-gated channel alpha subunit 10 multiple interactions
affects activity		 EXP cypermethrin affects the reaction [SCN10A protein results in increased transport of Sodium]
cypermethrin affects the activity of SCN10A protein		 CTD PMID:16051293 PMID:19766671 NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614 		JBrowse link
G Scn1b sodium voltage-gated channel beta subunit 1 multiple interactions EXP cypermethrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium]; SCN1B protein promotes the reaction [cypermethrin binds to SCN2A protein] CTD PMID:9863771 PMID:18538810 NCBI chr 1:86,353,917...86,363,836
Ensembl chr 1:86,353,917...86,363,739 		JBrowse link
G Scn2a sodium voltage-gated channel alpha subunit 2 affects binding
multiple interactions		 EXP cypermethrin binds to SCN2A protein
cypermethrin affects the reaction [[SCN2A protein binds to SCN1B protein] which results in increased transport of Sodium]; SCN1B protein promotes the reaction [cypermethrin binds to SCN2A protein]		 CTD PMID:9863771 PMID:18538810 NCBI chr 3:50,302,781...50,437,504
Ensembl chr 3:50,302,877...50,437,214 		JBrowse link
G Scn3a sodium voltage-gated channel alpha subunit 3 multiple interactions EXP cypermethrin affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium] CTD PMID:18538810 NCBI chr 3:50,146,411...50,258,119
Ensembl chr 3:50,148,139...50,258,119 		JBrowse link
G Scn3b sodium voltage-gated channel beta subunit 3 multiple interactions EXP cypermethrin affects the reaction [[SCN3A protein binds to SCN3B protein] which results in increased transport of Sodium] CTD PMID:18538810 NCBI chr 8:40,630,372...40,652,869
Ensembl chr 8:40,630,455...40,652,868 		JBrowse link
G Senp8 SUMO peptidase family member, NEDD8 specific increases expression ISO cypermethrin results in increased expression of SENP8 mRNA CTD PMID:29020013 NCBI chr 8:60,135,446...60,148,836
Ensembl chr 8:60,121,714...60,148,928 		JBrowse link
G Shbg sex hormone binding globulin affects binding
increases expression		 ISO cypermethrin binds to SHBG protein
cypermethrin results in increased expression of SHBG protein		 CTD PMID:30974244 PMID:32278787 NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057 		JBrowse link
G Sirt1 sirtuin 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SIRT1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260 		JBrowse link
G Slc18a2 solute carrier family 18 member A2 decreases expression EXP cypermethrin results in decreased expression of SLC18A2 mRNA CTD PMID:20815782 NCBI chr 1:258,413,748...258,449,143
Ensembl chr 1:258,413,959...258,448,325 		JBrowse link
G Slc2a2 solute carrier family 2 member 2 multiple interactions ISO cypermethrin promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of SLC2A2 mRNA] CTD PMID:24440342 NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933 		JBrowse link
G Slc41a3 solute carrier family 41, member 3 increases expression ISO cypermethrin results in increased expression of SLC41A3 mRNA CTD PMID:21142847 NCBI chr 4:123,109,555...123,154,766
Ensembl chr 4:123,112,748...123,154,766 		JBrowse link
G Slc5a5 solute carrier family 5 member 5 multiple interactions ISO cypermethrin inhibits the reaction [SLC5A5 protein results in increased uptake of Iodine] CTD PMID:27979590 NCBI chr16:18,546,709...18,556,698
Ensembl chr16:18,546,709...18,556,697 		JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression ISO cypermethrin results in increased expression of SLC7A11 mRNA CTD PMID:25424538 NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536 		JBrowse link
G Smim12 small integral membrane protein 12 increases expression ISO cypermethrin results in increased expression of SMIM12 mRNA CTD PMID:29020013 NCBI chr 5:139,569,367...139,573,276
Ensembl chr 5:139,569,391...139,574,320 		JBrowse link
G Snap25 synaptosome associated protein 25 decreases expression
multiple interactions		 EXP cypermethrin results in decreased expression of SNAP25 protein
Minocycline inhibits the reaction [cypermethrin results in decreased expression of SNAP25 protein]		 CTD PMID:21561882 NCBI chr 3:124,041,898...124,123,761
Ensembl chr 3:124,041,898...124,123,760 		JBrowse link
G Snca synuclein alpha multiple interactions
increases expression		 EXP
ISO		 Cyclosporine inhibits the reaction [cypermethrin promotes the reaction [SNCA protein binds to SNCA protein]]; Cyclosporine inhibits the reaction [cypermethrin results in increased expression of SNCA protein]; cypermethrin promotes the reaction [SNCA protein binds to SNCA protein]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [cypermethrin promotes the reaction [SNCA protein binds to SNCA protein]]; Mn(III) 5,10,15,20-tetrakis(N-methylpyridinium-2-yl)porphyrin inhibits the reaction [cypermethrin results in increased expression of SNCA protein]
cypermethrin results in increased expression of SNCA mRNA		 CTD PMID:25370934 PMID:27704156 NCBI chr 4:89,696,420...89,797,240
Ensembl chr 4:89,696,420...89,796,262 		JBrowse link
G Socs2 suppressor of cytokine signaling 2 multiple interactions
decreases expression		 ISO Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of SOCS2 mRNA] CTD PMID:31659573 NCBI chr 7:30,006,360...30,045,161
Ensembl chr 7:30,008,578...30,043,548 		JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions
increases expression
increases activity
decreases activity		 ISO
EXP		 [cypermethrin co-treated with Chlorpyrifos] results in decreased activity of SOD1 protein; Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in decreased activity of SOD1 protein]
cypermethrin results in increased expression of SOD1 mRNA
cypermethrin results in increased activity of SOD1 protein
cypermethrin results in decreased activity of SOD1 protein
[cypermethrin co-treated with fenvalerate] results in increased activity of SOD1 protein		 CTD PMID:10355540 PMID:12965126 PMID:15365239 PMID:15991261 PMID:21397294 More... NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249 		JBrowse link
G Sod2 superoxide dismutase 2 increases expression
affects expression		 ISO cypermethrin results in increased expression of SOD2 mRNA
cypermethrin affects the expression of SOD2 mRNA		 CTD PMID:21142847 PMID:21397294 PMID:32214279 NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189 		JBrowse link
G Sox9 SRY-box transcription factor 9 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994 		JBrowse link
G Spata2 spermatogenesis associated 2 increases expression ISO cypermethrin results in increased expression of SPATA2 mRNA CTD PMID:27704156 NCBI chr 3:156,202,962...156,213,283
Ensembl chr 3:156,202,967...156,211,705 		JBrowse link
G Spi1 Spi-1 proto-oncogene multiple interactions ISO Acetylcysteine inhibits the reaction [cypermethrin inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA]]; cypermethrin inhibits the reaction [Tretinoin results in increased expression of SPI1 mRNA] CTD PMID:29945211 NCBI chr 3:77,059,744...77,093,730
Ensembl chr 3:77,073,012...77,092,393 		JBrowse link
G Spp1 secreted phosphoprotein 1 decreases expression ISO cypermethrin results in decreased expression of SPP1 mRNA CTD PMID:29020013 NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162 		JBrowse link
G Sqstm1 sequestosome 1 increases expression ISO cypermethrin results in increased expression of SQSTM1 mRNA CTD PMID:27704156 NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673 		JBrowse link
G Src SRC proto-oncogene, non-receptor tyrosine kinase multiple interactions ISO [cypermethrin results in decreased susceptibility to Dihydrotestosterone] which results in decreased phosphorylation of SRC protein; cypermethrin inhibits the reaction [AR protein binds to SRC protein] CTD PMID:30974244 NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476 		JBrowse link
G Srd5a2 steroid 5 alpha-reductase 2 increases expression ISO cypermethrin results in increased expression of SRD5A2 mRNA CTD PMID:21142847 NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112 		JBrowse link
G Srm spermidine synthase increases expression ISO cypermethrin results in increased expression of SRM mRNA CTD PMID:32573024 NCBI chr 5:159,025,919...159,029,076
Ensembl chr 5:159,025,873...159,029,405 		JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO cypermethrin results in increased expression of SRXN1 mRNA CTD PMID:21142847 NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448 		JBrowse link
G Star steroidogenic acute regulatory protein decreases expression
multiple interactions
increases expression		 ISO
EXP		 cypermethrin results in decreased expression of STAR mRNA; cypermethrin results in decreased expression of STAR protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of STAR mRNA
cypermethrin results in increased expression of STAR mRNA
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]; Egtazic Acid inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]; Nimodipine inhibits the reaction [cypermethrin results in increased expression of STAR mRNA]		 CTD PMID:19862501 PMID:21397294 PMID:21560301 PMID:24810582 PMID:28731686 More... NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672 		JBrowse link
G Stat4 signal transducer and activator of transcription 4 decreases expression
multiple interactions		 EXP
ISO		 cypermethrin results in decreased expression of STAT4 mRNA
Sodium Selenite inhibits the reaction [cypermethrin results in decreased expression of STAT4 mRNA]		 CTD PMID:22528246 PMID:31659573 NCBI chr 9:49,472,660...49,588,540
Ensembl chr 9:49,419,340...49,588,540 		JBrowse link
G Stat5a signal transducer and activator of transcription 5A decreases expression EXP cypermethrin results in decreased expression of STAT5A mRNA CTD PMID:22528246 NCBI chr10:85,785,537...85,809,869
Ensembl chr10:85,785,537...85,809,866 		JBrowse link
G Stmn1 stathmin 1 decreases expression
multiple interactions		 EXP cypermethrin results in decreased expression of STMN1 protein
Minocycline inhibits the reaction [cypermethrin results in decreased expression of STMN1 protein]		 CTD PMID:21561882 NCBI chr 5:146,680,757...146,687,154
Ensembl chr 5:146,681,436...146,687,154 		JBrowse link
G Stra8 stimulated by retinoic acid 8 decreases expression ISO cypermethrin results in decreased expression of STRA8 mRNA CTD PMID:24810582 NCBI chr 4:63,601,443...63,624,777
Ensembl chr 4:63,601,604...63,624,771 		JBrowse link
G Sycp2 synaptonemal complex protein 2 increases expression ISO cypermethrin results in increased expression of SYCP2 mRNA CTD PMID:27704156 NCBI chr 3:165,431,715...165,502,134
Ensembl chr 3:165,436,331...165,498,789 		JBrowse link
G Syn1 synapsin I decreases expression ISO cypermethrin results in decreased expression of SYN1 mRNA CTD PMID:32028016 NCBI chr  X:1,172,208...1,227,400
Ensembl chr  X:1,172,208...1,227,396 		JBrowse link
G Taf7 TATA-box binding protein associated factor 7 increases expression ISO cypermethrin results in increased expression of TAF7 mRNA CTD PMID:29020013 NCBI chr18:29,459,937...29,462,086
Ensembl chr18:29,452,943...29,462,134 		JBrowse link
G Tat tyrosine aminotransferase multiple interactions EXP cypermethrin inhibits the reaction [Hydrocortisone results in increased expression of TAT mRNA] CTD PMID:26647222 NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031 		JBrowse link
G Tbxt T-box transcription factor T affects expression ISO cypermethrin affects the expression of T mRNA CTD PMID:32214279 NCBI chr 1:52,298,099...52,309,813
Ensembl chr 1:52,298,099...52,305,864 		JBrowse link
G Terf1 telomeric repeat binding factor 1 increases expression ISO cypermethrin results in increased expression of TERF1 mRNA CTD PMID:21142847 NCBI chr 5:3,443,103...3,472,377
Ensembl chr 5:3,443,106...3,472,340 		JBrowse link
G Tet1 tet methylcytosine dioxygenase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TET1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052 		JBrowse link
G Tf transferrin increases expression ISO cypermethrin results in increased expression of TRF protein CTD PMID:30974244 NCBI chr 8:103,789,780...103,816,487
Ensembl chr 8:103,767,995...103,816,511 		JBrowse link
G Tff1 trefoil factor 1 increases expression ISO cypermethrin results in increased expression of TFF1 mRNA CTD PMID:12396874 PMID:20397420 NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGFB1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847 		JBrowse link
G Th tyrosine hydroxylase decreases expression EXP cypermethrin results in decreased expression of TH mRNA; cypermethrin results in decreased expression of TH protein CTD PMID:26115703 NCBI chr 1:198,071,500...198,078,832
Ensembl chr 1:198,071,503...198,109,767 		JBrowse link
G Thy1 Thy-1 cell surface antigen multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of THY1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of THY1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659 		JBrowse link
G Timm10 translocase of inner mitochondrial membrane 10 increases expression ISO cypermethrin results in increased expression of TIMM10 mRNA CTD PMID:29020013 NCBI chr 3:69,908,397...69,911,943
Ensembl chr 3:69,908,456...69,911,940 		JBrowse link
G Timm8a1 translocase of inner mitochondrial membrane 8A1 increases expression ISO cypermethrin results in increased expression of TIMM8A1 mRNA CTD PMID:29020013 NCBI chr  X:97,717,932...97,721,918
Ensembl chr  X:97,717,920...97,721,960 		JBrowse link
G Tmed2 transmembrane p24 trafficking protein 2 decreases expression EXP cypermethrin results in decreased expression of TMED2 mRNA CTD PMID:22528246 NCBI chr12:32,052,542...32,061,596
Ensembl chr12:32,052,543...32,071,903 		JBrowse link
G Tmem74 transmembrane protein 74 increases expression ISO cypermethrin results in increased expression of TMEM74 mRNA CTD PMID:29020013 NCBI chr 7:74,929,286...74,937,973
Ensembl chr 7:74,931,694...74,937,934 		JBrowse link
G Tmod1 tropomodulin 1 increases expression ISO cypermethrin results in increased expression of TMOD1 mRNA CTD PMID:21142847 NCBI chr 5:60,316,445...60,393,957
Ensembl chr 5:60,338,512...60,393,956 		JBrowse link
G Tnf tumor necrosis factor affects expression
multiple interactions
increases expression		 EXP
ISO		 cypermethrin affects the expression of TNF
cypermethrin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]
cypermethrin results in increased expression of TNF protein
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TNF protein]; Sesame Oil affects the reaction [cypermethrin affects the expression of TNF]		 CTD PMID:23900960 PMID:25816392 PMID:29471534 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629 		JBrowse link
G Tnp1 transition protein 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TNP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274 		JBrowse link
G Tnp2 transition protein 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP2 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538 		JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions
increases mutagenesis
decreases expression		 EXP
ISO		 cypermethrin results in increased expression of TP53 mRNA; cypermethrin results in increased expression of TP53 protein
Acetylcysteine inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA]
cypermethrin results in increased mutagenesis of TP53 exon
cypermethrin results in decreased expression of TP53 mRNA
Vitamin E inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA]		 CTD PMID:22528246 PMID:24759048 PMID:27704156 PMID:28584332 PMID:29945211 More... NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524 		JBrowse link
G Tph1 tryptophan hydroxylase 1 decreases expression EXP cypermethrin results in decreased expression of TPH1 mRNA; cypermethrin results in decreased expression of TPH1 protein CTD PMID:26115703 NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344 		JBrowse link
G Trdmt1 tRNA aspartic acid methyltransferase 1 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRDMT1 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439 		JBrowse link
G Trex1 three prime repair exonuclease 1 increases expression ISO cypermethrin results in increased expression of TREX1 mRNA CTD PMID:21142847 NCBI chr 8:109,706,613...109,707,913
Ensembl chr 8:109,706,613...109,708,796 		JBrowse link
G Trmt9b tRNA methyltransferase 9B (putative) increases expression ISO cypermethrin results in increased expression of TRMT9B mRNA CTD PMID:29020013 NCBI chr16:55,740,551...55,792,198
Ensembl chr16:55,743,018...55,792,144 		JBrowse link
G Trpc2 transient receptor potential cation channel subfamily C member 2 increases expression ISO cypermethrin results in increased expression of TRPC2 mRNA CTD PMID:21142847 NCBI chr 1:156,460,009...156,473,039
Ensembl chr 1:156,440,305...156,473,073 		JBrowse link
G Trpm2 transient receptor potential cation channel, subfamily M, member 2 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TRPM2 mRNA CTD PMID:33396045 NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181 		JBrowse link
G Tspo translocator protein multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSPO mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450 		JBrowse link
G Ttc30b tetratricopeptide repeat domain 30B increases expression ISO cypermethrin results in increased expression of TTC30B mRNA CTD PMID:29020013 NCBI chr 3:60,855,809...60,858,380
Ensembl chr 3:60,855,575...60,858,389 		JBrowse link
G Tubb3 tubulin, beta 3 class III increases expression ISO cypermethrin results in increased expression of TUBB3 mRNA CTD PMID:32028016 NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243 		JBrowse link
G Txnip thioredoxin interacting protein increases expression
decreases expression		 ISO cypermethrin results in increased expression of TXNIP mRNA
cypermethrin results in decreased expression of TXNIP mRNA		 CTD PMID:21142847 PMID:29020013 NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886 		JBrowse link
G Txnl4b thioredoxin-like 4B increases expression ISO cypermethrin results in increased expression of TXNL4B mRNA CTD PMID:27704156 NCBI chr19:37,530,157...37,539,827
Ensembl chr19:37,530,152...37,538,521 		JBrowse link
G Txnrd2 thioredoxin reductase 2 increases expression ISO cypermethrin results in increased expression of TXNRD2 mRNA CTD PMID:21142847 NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156 		JBrowse link
G Txnrd3 thioredoxin reductase 3 increases expression ISO cypermethrin results in increased expression of TXNRD3 mRNA CTD PMID:21142847 NCBI chr 4:122,072,548...122,112,493
Ensembl chr 4:122,072,548...122,112,491 		JBrowse link
G Ubb ubiquitin B decreases expression EXP cypermethrin results in decreased expression of UBB mRNA CTD PMID:22528246 NCBI chr10:47,247,629...47,249,335
Ensembl chr10:47,245,637...47,249,333 		JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 affects expression
increases expression		 ISO cypermethrin affects the expression of UGT1A6 mRNA
cypermethrin results in increased expression of UGT1A6		 CTD PMID:32214279 NCBI chr 9:88,747,229...88,808,465
Ensembl chr 9:88,713,184...88,808,465 		JBrowse link
G Ulk1 unc-51 like autophagy activating kinase 1 increases expression ISO cypermethrin results in increased expression of ULK1 mRNA CTD PMID:27704156 NCBI chr12:45,851,710...45,877,966
Ensembl chr12:45,851,710...45,877,966 		JBrowse link
G Ung uracil-DNA glycosylase increases expression ISO cypermethrin results in increased expression of UNG mRNA CTD PMID:21142847 NCBI chr12:42,485,276...42,494,217
Ensembl chr12:42,485,276...42,494,206 		JBrowse link
G Vegfc vascular endothelial growth factor C decreases expression EXP cypermethrin results in decreased expression of VEGFC mRNA CTD PMID:22528246 NCBI chr16:37,712,408...37,827,657
Ensembl chr16:37,712,262...37,827,848 		JBrowse link
G Vim vimentin increases expression
multiple interactions
decreases expression		 ISO
EXP		 cypermethrin results in increased expression of VIM mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of VIM mRNA; [cypermethrin co-treated with Diethylhexyl Phthalate] results in decreased expression of VIM mRNA
cypermethrin results in decreased expression of VIM mRNA		 CTD PMID:21142847 PMID:22528246 PMID:24641848 PMID:33051911 PMID:33396045 NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187 		JBrowse link
G Vldlr very low density lipoprotein receptor increases expression ISO cypermethrin results in increased expression of VLDLR mRNA CTD PMID:25424538 NCBI chr 1:224,813,539...224,850,400
Ensembl chr 1:224,814,377...224,845,920 		JBrowse link
G Vpreb1 V-set pre-B cell surrogate light chain 1 decreases expression ISO cypermethrin results in decreased expression of VPREB1 mRNA CTD PMID:25424538 NCBI chr11:84,126,969...84,127,846
Ensembl chr11:84,126,969...84,127,846 		JBrowse link
G Wnt1 Wnt family member 1 multiple interactions EXP [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WNT1 mRNA CTD PMID:33396045 NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651 		JBrowse link
G Wnt3a Wnt family member 3A increases expression ISO cypermethrin results in increased expression of WNT3A mRNA CTD PMID:32028016 NCBI chr10:44,034,174...44,078,463
Ensembl chr10:44,034,194...44,078,324 		JBrowse link
G Wnt4 Wnt family member 4 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859 		JBrowse link
G Wnt5a Wnt family member 5A increases expression ISO cypermethrin results in increased expression of WNT5A mRNA CTD PMID:32028016 NCBI chr16:3,695,667...3,718,234
Ensembl chr16:3,697,032...3,718,234 		JBrowse link
G Wnt7a Wnt family member 7A increases expression ISO cypermethrin results in increased expression of WNT7A mRNA CTD PMID:32028016 NCBI chr 4:123,863,108...123,908,981
Ensembl chr 4:123,863,108...123,908,981 		JBrowse link
G Wrn WRN RecQ like helicase increases expression ISO cypermethrin results in increased expression of WRN mRNA CTD PMID:21142847 NCBI chr16:58,763,517...58,898,604
Ensembl chr16:58,763,504...58,895,450 		JBrowse link
G Xiap X-linked inhibitor of apoptosis increases expression ISO cypermethrin results in increased expression of XIAP mRNA CTD PMID:27704156 NCBI chr  X:120,890,537...120,938,413
Ensembl chr  X:120,897,907...120,934,700 		JBrowse link
G Xpnpep3 X-prolyl aminopeptidase 3 increases expression ISO cypermethrin results in increased expression of XPNPEP3 mRNA CTD PMID:29020013 NCBI chr 7:112,926,154...112,978,793
Ensembl chr 7:112,926,248...112,974,878 		JBrowse link
G Ybx1 Y box binding protein 1 increases expression EXP cypermethrin results in increased expression of YBX1 mRNA CTD PMID:22528246 NCBI chr 5:132,882,137...132,899,108
Ensembl chr 5:132,882,145...132,898,862 		JBrowse link
G Ybx2 Y box binding protein 2 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371 		JBrowse link
G Zbtb16 zinc finger and BTB domain containing 16 multiple interactions EXP [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA CTD PMID:33051911 PMID:33396045 NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011 		JBrowse link
G Zfp300 zinc finger protein 300 increases expression ISO cypermethrin results in increased expression of ZFP300 mRNA CTD PMID:29020013 NCBI chr  X:899,469...921,285
Ensembl chr  X:913,805...918,292 		JBrowse link
G Zfp36l2 zinc finger protein 36, C3H type-like 2 increases expression ISO cypermethrin results in increased expression of ZFP36L2 mRNA CTD PMID:29020013 NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064 		JBrowse link
G Zfp709 zinc finger protein 709 increases expression ISO cypermethrin results in increased expression of ZFP709 mRNA CTD PMID:29020013 NCBI chr16:17,907,599...17,920,047
Ensembl chr16:17,909,641...17,919,700 		JBrowse link
methiocarb term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ache acetylcholinesterase decreases activity EXP Methiocarb results in decreased activity of ACHE protein CTD PMID:19934164 NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651 		JBrowse link
G Alb albumin increases hydrolysis
multiple interactions		 ISO
EXP		 ALB protein results in increased hydrolysis of Methiocarb
bis(4-nitrophenyl)phosphate inhibits the reaction [ALB protein results in increased hydrolysis of Methiocarb]		 CTD PMID:27665777 NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836 		JBrowse link
G Ar androgen receptor multiple interactions ISO
EXP		 Dihydrotestosterone inhibits the reaction [Methiocarb results in increased activity of AR protein]; Methiocarb inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Methiocarb inhibits the reaction [Metribolone results in increased activity of AR protein]
Methiocarb inhibits the reaction [Metribolone results in increased expression of AR mRNA]		 CTD PMID:15064155 PMID:15519604 PMID:18324785 PMID:21310686 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Bche butyrylcholinesterase multiple interactions EXP [Carbaryl co-treated with Propoxur co-treated with Methiocarb co-treated with Methomyl co-treated with formetanate co-treated with oxamyl co-treated with Carbofuran] affects the activity of BCHE protein CTD PMID:22649187 NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148 		JBrowse link
G Cyp2b3 cytochrome P450, family 2, subfamily b, polypeptide 3 multiple interactions
increases metabolic processing		 ISO [CYP2B6 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143 		JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 increases metabolic processing
multiple interactions		 ISO CYP2C19 protein results in increased metabolism of Methiocarb
[CYP2C19 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide		 CTD PMID:27665777 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 increases metabolic processing
multiple interactions		 ISO CYP2D6 protein results in increased metabolism of Methiocarb
[CYP2D6 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide		 CTD PMID:27665777 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759 		JBrowse link
G Esr1 estrogen receptor 1 increases activity
increases expression		 ISO Methiocarb results in increased activity of ESR1 protein
Methiocarb results in increased expression of ESR1 protein		 CTD PMID:15064155 PMID:19206145 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002 		JBrowse link
G Esr2 estrogen receptor 2 increases activity
increases expression		 ISO Methiocarb results in increased activity of ESR2 protein
Methiocarb results in increased expression of ESR2 mRNA		 CTD PMID:15064155 PMID:15130599 NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions
increases metabolic processing		 ISO [FMO1 protein results in increased metabolism of Methiocarb] which results in increased abundance of methiocarb sulfoxide CTD PMID:27665777 NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647 		JBrowse link
G Il2 interleukin 2 decreases response to substance ISO Methiocarb results in decreased susceptibility to IL2 protein CTD PMID:8349949 NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566 		JBrowse link
G Lhb luteinizing hormone subunit beta decreases expression EXP Methiocarb results in decreased expression of LHB protein CTD PMID:15519604 NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972 		JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases activity EXP Methiocarb results in increased activity of NR1I2 protein CTD PMID:27665777 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658 		JBrowse link
G Odc1 ornithine decarboxylase 1 decreases expression EXP Methiocarb results in decreased expression of ODC1 mRNA CTD PMID:15519604 NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440 		JBrowse link
G Ppara peroxisome proliferator activated receptor alpha increases activity EXP Methiocarb results in increased activity of PPARA protein CTD PMID:27665777 NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [Methiocarb binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 CTD PMID:26359731 NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188 		JBrowse link
G Scgb2a1 secretoglobin, family 2A, member 1 decreases expression EXP Methiocarb results in decreased expression of SCGB2A2 mRNA CTD PMID:15519604 NCBI chr 1:206,497,848...206,501,211
Ensembl chr 1:206,497,849...206,501,211
Ensembl chr 1:206,497,849...206,501,211 		JBrowse link
niclosamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acaca acetyl-CoA carboxylase alpha decreases expression ISO Niclosamide results in decreased expression of ACACA mRNA CTD PMID:22576131 NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant multiple interactions ISO Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 mRNA]
Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA]		 CTD PMID:26792726 PMID:28824321 NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:20,663,985...20,667,929 		JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO Niclosamide results in decreased expression of ACSL1 mRNA CTD PMID:22576131 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541 		JBrowse link
G Acta2 actin alpha 2, smooth muscle multiple interactions ISO Niclosamide inhibits the reaction [Doxorubicin results in increased expression of ACTA2 protein]
Niclosamide inhibits the reaction [[Lapatinib results in decreased susceptibility to Lapatinib] which results in increased expression of ACTA2 protein]		 CTD PMID:26643609 PMID:28318631 NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide decreases expression ISO Niclosamide results in decreased expression of ADH4 mRNA CTD PMID:28284560 NCBI chr 2:226,948,717...226,966,747
Ensembl chr 2:226,947,466...226,987,591 		JBrowse link
G Afp alpha-fetoprotein multiple interactions EXP Niclosamide inhibits the reaction [Thioacetamide results in increased expression of AFP protein]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of AFP protein]] CTD PMID:32961231 NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480 		JBrowse link
G Aifm1 apoptosis inducing factor, mitochondria associated 1 increases cleavage ISO Niclosamide results in increased cleavage of AIFM1 protein CTD PMID:22576131 NCBI chr  X:127,650,223...127,689,356
Ensembl chr  X:127,650,226...127,689,256 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases expression
multiple interactions		 ISO Niclosamide results in increased expression of AKT1 mRNA
Niclosamide inhibits the reaction [TNF protein results in increased activity of AKT1 protein]; Niclosamide inhibits the reaction [TNFSF11 protein results in increased phosphorylation of AKT1 protein]		 CTD PMID:20215516 PMID:26792726 PMID:29843133 NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression ISO Niclosamide results in decreased expression of ALDH1A1 protein CTD PMID:24736023 NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961 		JBrowse link
G Aldob aldolase, fructose-bisphosphate B increases expression ISO Niclosamide results in increased expression of ALDOB mRNA CTD PMID:22576131 NCBI chr 5:63,889,045...63,902,086
Ensembl chr 5:63,889,046...63,902,116 		JBrowse link
G Aldoc aldolase, fructose-bisphosphate C decreases expression ISO Niclosamide results in decreased expression of ALDOC mRNA CTD PMID:22576131 NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,217,451...63,221,066 		JBrowse link
G Alox12b arachidonate 12-lipoxygenase, 12R type increases expression
multiple interactions
decreases response to substance		 ISO Niclosamide results in increased expression of ALOX12B mRNA
TP53 gene mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX12B mRNA]; TP53 protein mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX12B mRNA]
ALOX12B protein results in decreased susceptibility to Niclosamide		 CTD PMID:30258081 NCBI chr10:53,863,060...53,874,938
Ensembl chr10:53,863,060...53,874,938 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions
decreases response to substance
increases expression		 ISO TP53 gene mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX5 mRNA]; TP53 protein mutant form inhibits the reaction [Niclosamide results in increased expression of ALOX5 mRNA]
ALOX5 protein results in decreased susceptibility to Niclosamide		 CTD PMID:30258081 NCBI chr 4:149,531,329...149,578,696
Ensembl chr 4:149,531,515...149,578,743 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated decreases expression ISO Niclosamide results in decreased expression of ALPL mRNA CTD PMID:28824321 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446 		JBrowse link
G Apof apolipoprotein F decreases expression ISO Niclosamide results in decreased expression of APOF mRNA CTD PMID:28284560 NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946 		JBrowse link
G Ar androgen receptor multiple interactions
decreases expression		 ISO [enzalutamide co-treated with Niclosamide] results in decreased expression of AR protein; [Niclosamide inhibits the reaction [AR protein binds to KLK3 promoter]] which results in decreased expression of KLK3 protein; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Niclosamide results in decreased expression of and results in increased degradation of AR protein alternative form]; bicalutamide promotes the reaction [Niclosamide inhibits the reaction [AR protein binds to KLK3 promoter]]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein alternative form]; bicalutamide promotes the reaction [Niclosamide results in decreased expression of AR protein]; Niclosamide inhibits the reaction [AR protein alternative form binds to KLK3 promoter]; Niclosamide inhibits the reaction [AR protein alternative form results in decreased susceptibility to enzalutamide]; Niclosamide inhibits the reaction [AR protein alternative form results in increased expression of KLK3 mRNA]; Niclosamide inhibits the reaction [AR protein alternative form results in increased expression of KLK3 protein]; Niclosamide inhibits the reaction [AR protein binds to KLK3 promoter]; Niclosamide inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA]; Niclosamide results in decreased expression of and results in increased degradation of AR protein alternative form
Niclosamide results in decreased expression of AR protein; Niclosamide results in decreased expression of AR protein alternative form		 CTD PMID:24740322 PMID:25970160 PMID:28500234 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925 		JBrowse link
G Araf A-Raf proto-oncogene, serine/threonine kinase decreases expression ISO Niclosamide analog results in decreased expression of ARAF protein; Niclosamide results in decreased expression of ARAF protein CTD PMID:28284560 NCBI chr  X:1,227,392...1,292,356
Ensembl chr  X:1,227,392...1,239,073 		JBrowse link
G Asf1b anti-silencing function 1B histone chaperone decreases expression ISO Niclosamide results in decreased expression of ASF1B mRNA CTD PMID:28284560 NCBI chr19:24,181,024...24,195,604
Ensembl chr19:24,181,028...24,195,549 		JBrowse link
G Atf3 activating transcription factor 3 increases expression
multiple interactions		 ISO Niclosamide results in increased expression of ATF3 mRNA; Niclosamide results in increased expression of ATF3 protein
ATF3 protein affects the reaction [Niclosamide results in increased cleavage of CASP3 protein]; ATF3 protein affects the reaction [Niclosamide results in increased expression of DDIT3 mRNA]; ATF3 protein affects the reaction [Niclosamide results in increased expression of EIF2AK3 mRNA]		 CTD PMID:26917416 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631 		JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO Niclosamide results in increased expression of ATF4 mRNA; Niclosamide results in increased expression of ATF4 protein CTD PMID:26917416 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:111,804,183...111,806,446 		JBrowse link
G Atp5f1a ATP synthase F1 subunit alpha increases expression ISO Niclosamide results in increased expression of ATP5F1A mRNA CTD PMID:22576131 NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794 		JBrowse link
G Atp5f1d ATP synthase F1 subunit delta increases expression ISO Niclosamide results in increased expression of ATP5F1D mRNA CTD PMID:22576131 NCBI chr 7:9,560,604...9,565,919
Ensembl chr 7:9,560,608...9,565,929 		JBrowse link
G Atp5mc3 ATP synthase membrane subunit c locus 3 decreases expression ISO Niclosamide results in decreased expression of ATP5MC3 mRNA CTD PMID:22576131 NCBI chr 3:58,810,535...58,813,185
Ensembl chr 3:58,810,535...58,814,279 		JBrowse link
G Atp5mf ATP synthase membrane subunit f decreases expression ISO Niclosamide results in decreased expression of ATP5MF mRNA CTD PMID:22576131 NCBI chr12:9,421,665...9,428,236
Ensembl chr12:9,421,579...9,428,236 		JBrowse link
G Atp5mg ATP synthase membrane subunit g decreases expression ISO Niclosamide results in decreased expression of ATP5MG mRNA CTD PMID:22576131 NCBI chr 8:45,226,750...45,233,582
Ensembl chr 8:45,225,686...45,233,559 		JBrowse link
G Atp5pb ATP synthase peripheral stalk-membrane subunit b decreases expression ISO Niclosamide results in decreased expression of ATP5PB mRNA CTD PMID:22576131 NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418 		JBrowse link
G Atp6ap1 ATPase H+ transporting accessory protein 1 decreases expression ISO Niclosamide results in decreased expression of ATP6AP1 mRNA CTD PMID:22576131 NCBI chr  X:152,079,954...152,087,034
Ensembl chr  X:152,079,865...152,087,034 		JBrowse link
G Atp6v0d2 ATPase H+ transporting V0 subunit D2 multiple interactions ISO Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of ATP6V0D2 mRNA] CTD PMID:26792726 NCBI chr 5:33,336,257...33,385,354
Ensembl chr 5:33,336,264...33,385,354 		JBrowse link
G Aurkb aurora kinase B decreases expression ISO Niclosamide results in decreased expression of AURKB mRNA CTD PMID:28284560 NCBI chr10:53,744,290...53,750,831
Ensembl chr10:53,745,142...53,750,837 		JBrowse link
G Axin2 axin 2 multiple interactions
decreases expression		 ISO Niclosamide inhibits the reaction [Lithium Chloride results in increased expression of AXIN2 mRNA]
Niclosamide results in decreased expression of AXIN2 mRNA; Niclosamide results in decreased expression of AXIN2 protein		 CTD PMID:22576131 PMID:24534281 PMID:24552774 PMID:24736023 NCBI chr10:93,893,830...93,927,042
Ensembl chr10:93,899,245...93,926,231 		JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions ISO [Niclosamide binds to Polyethyleneimine] which results in increased expression of BAD mRNA CTD PMID:25988281 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:204,131,501...204,142,823 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions ISO [Niclosamide binds to Polyethyleneimine] which results in increased expression of BAK1 mRNA CTD PMID:25988281 NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression
multiple interactions
decreases expression		 ISO Niclosamide results in increased expression of BAX protein
[Niclosamide binds to Polyethyleneimine] which results in increased expression of BAX mRNA; [Niclosamide co-treated with bicalutamide] results in increased expression of BAX protein; bicalutamide inhibits the reaction [Niclosamide results in decreased expression of BAX protein]		 CTD PMID:25634333 PMID:25988281 PMID:26703449 PMID:28500234 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368 		JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions
increases expression		 ISO TP53 gene mutant form inhibits the reaction [Niclosamide results in increased expression of BBC3 mRNA] CTD PMID:30258081 NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509 		JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression
multiple interactions		 ISO Niclosamide analog results in decreased expression of BCL2 protein; Niclosamide results in decreased expression of BCL2 protein
[Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2 mRNA; [Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2 protein]] which results in increased susceptibility to Erlotinib Hydrochloride; bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2 protein]; Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2 protein]; Niclosamide inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2 protein]		 CTD PMID:20215516 PMID:23894143 PMID:25634333 PMID:25988281 PMID:26116531 More... NCBI chr13:22,689,783...22,853,920 JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions
decreases expression		 ISO [Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2L1 mRNA; bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2L1 protein]; Niclosamide inhibits the reaction [TNF protein results in increased expression of BCL2L1 mRNA]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2L1 protein]
Niclosamide analog results in decreased expression of BCL2L1 protein; Niclosamide results in decreased expression of BCL2L1 protein		 CTD PMID:20215516 PMID:25988281 PMID:26116531 PMID:28284560 PMID:28500234 NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 		JBrowse link
G Bcl2l2 Bcl2-like 2 decreases expression
multiple interactions		 ISO Niclosamide results in decreased expression of BCL2L2 protein
[Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L2 protein]] which results in increased susceptibility to Erlotinib Hydrochloride; Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2L2 protein]		 CTD PMID:23894143 NCBI chr15:28,346,449...28,361,627
Ensembl chr15:28,356,807...28,361,624 		JBrowse link
G Bcl6 BCL6, transcription repressor multiple interactions ISO Niclosamide affects the reaction [FAS protein mutant form affects the expression of BCL6 mRNA]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of BCL6 protein] CTD PMID:33632240 NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389 		JBrowse link
G Bcl9 BCL9, transcription coactivator decreases expression EXP Niclosamide results in decreased expression of BCL9 mRNA CTD PMID:27338550 NCBI chr 2:184,760,616...184,846,261
Ensembl chr 2:184,760,618...184,786,435 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions
affects expression
decreases expression		 ISO enzalutamide promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein]; Niclosamide inhibits the reaction [IL6 protein results in increased expression of BIRC5 protein]
Niclosamide affects the expression of BIRC5 protein
Niclosamide analog results in decreased expression of BIRC5 protein; Niclosamide results in decreased expression of BIRC5 protein		 CTD PMID:24552774 PMID:24736023 PMID:25970160 PMID:28284560 PMID:28500234 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380 		JBrowse link
G Braf B-Raf proto-oncogene, serine/threonine kinase decreases expression
decreases phosphorylation		 ISO Niclosamide analog results in decreased expression of BRAF protein; Niclosamide results in decreased expression of BRAF protein
Niclosamide analog results in decreased phosphorylation of BRAF protein		 CTD PMID:28284560 NCBI chr 4:68,375,484...68,510,652
Ensembl chr 4:68,384,649...68,510,463 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO [Niclosamide co-treated with Adenosine Triphosphate co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of CASP1 protein
Niclosamide inhibits the reaction [[Adenosine Triphosphate co-treated with lipopolysaccharide, E coli O55-B5] results in increased cleavage of CASP1 protein]		 CTD PMID:33524445 NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383 		JBrowse link
G Casp3 caspase 3 increases cleavage
multiple interactions
increases expression
decreases expression		 ISO
EXP		 Niclosamide results in increased cleavage of CASP3 protein
Niclosamide inhibits the reaction [Thioacetamide results in decreased expression of CASP3 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in decreased expression of CASP3 mRNA]]
[TP53 protein mutant form results in increased susceptibility to Niclosamide] which results in increased expression of CASP3 protein modified form; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CASP3 protein modified form]
Niclosamide results in increased expression of CASP3 protein modified form
Niclosamide results in decreased expression of CASP3 protein
7-methyl-5-(1-((3-(trifluoromethyl)phenyl)acetyl)-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine inhibits the reaction [Niclosamide results in increased cleavage of CASP3 protein]; [Niclosamide binds to Polyethyleneimine] which results in increased expression of CASP3 mRNA; ATF3 protein affects the reaction [Niclosamide results in increased cleavage of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid inhibits the reaction [Niclosamide results in increased cleavage of CASP3 protein]; TP53 gene mutant form promotes the reaction [Niclosamide results in increased cleavage of CASP3 protein]; WNT7A protein affects the reaction [Niclosamide results in increased cleavage of CASP3 protein]		 CTD PMID:20215516 PMID:21871175 PMID:24750999 PMID:25174399 PMID:25634333 More... NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648 		JBrowse link
G Casp7 caspase 7 multiple interactions
increases expression		 ISO bicalutamide promotes the reaction [Niclosamide results in increased expression of CASP7 protein modified form] CTD PMID:26116531 PMID:28500234 NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729 		JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression
increases cleavage		 ISO TP53 gene mutant form promotes the reaction [Niclosamide results in increased cleavage of CASP9 protein]
Niclosamide results in increased expression of CASP9 protein modified form		 CTD PMID:26116531 PMID:26703449 PMID:30258081 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions ISO
EXP		 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of CCL2 mRNA]; Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of CCL2 mRNA]		 CTD PMID:24561310 PMID:28318631 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226 		JBrowse link
G Ccl20 C-C motif chemokine ligand 20 multiple interactions ISO
EXP		 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of CCL20 mRNA]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of CCL20 mRNA]		 CTD PMID:28318631 NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:84,388,904...84,391,629 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein] CTD PMID:24561310 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO Niclosamide inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL5 protein] CTD PMID:24561310 NCBI chr10:68,322,826...68,327,365
Ensembl chr10:68,322,829...68,327,377 		JBrowse link
G Ccnb1 cyclin B1 decreases expression ISO Niclosamide results in decreased expression of CCNB1 mRNA CTD PMID:28284560 NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions
decreases expression		 EXP
ISO		 Niclosamide inhibits the reaction [Epinephrine results in increased expression of CCND1 mRNA]; Niclosamide inhibits the reaction [GCG protein results in increased expression of CCND1 mRNA]; Niclosamide inhibits the reaction [GCG protein results in increased expression of CCND1 protein]; Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CCND1 mRNA]; Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CCND1 protein]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CCND1 mRNA]]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CCND1 protein]]
Niclosamide results in decreased expression of CCND1 mRNA
Niclosamide analog results in decreased expression of CCND1 protein; Niclosamide results in decreased expression of CCND1 mRNA; Niclosamide results in decreased expression of CCND1 protein
Niclosamide inhibits the reaction [IL6 protein results in increased expression of CCND1 mRNA]; Niclosamide inhibits the reaction [TNF protein results in increased expression of CCND1 mRNA]; Niclosamide promotes the reaction [bicalutamide results in decreased expression of CCND1 protein]		 CTD PMID:19160421 PMID:20215516 PMID:24552774 PMID:24736023 PMID:26297436 More... NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602 		JBrowse link
G Ccnd2 cyclin D2 decreases expression
increases expression		 ISO Niclosamide results in decreased expression of CCND2 mRNA
Niclosamide results in increased expression of CCND2 mRNA		 CTD PMID:22576131 PMID:27226553 NCBI chr 4:159,966,883...159,989,261
Ensembl chr 4:159,962,363...159,989,495 		JBrowse link
G Ccnd3 cyclin D3 decreases expression ISO Niclosamide results in decreased expression of CCND3 mRNA CTD PMID:22576131 PMID:27226553 NCBI chr 9:13,394,161...13,400,341
Ensembl chr 9:13,394,169...13,489,371 		JBrowse link
G Ccne2 cyclin E2 multiple interactions ISO Niclosamide inhibits the reaction [PIK3CA protein modified form results in increased expression of CCNE2 mRNA] CTD PMID:27542212 NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632 		JBrowse link
G Ccng2 cyclin G2 multiple interactions ISO Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of CCNG2 mRNA] CTD PMID:27542212 NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830 		JBrowse link
G Cd40 CD40 molecule multiple interactions ISO Niclosamide inhibits the reaction [Lipopolysaccharides affects the expression of CD40 protein] CTD PMID:24561310 NCBI chr 3:153,790,372...153,805,279
Ensembl chr 3:153,790,449...153,805,534 		JBrowse link
G Cd80 Cd80 molecule multiple interactions ISO Niclosamide inhibits the reaction [Lipopolysaccharides affects the expression of CD80 protein] CTD PMID:24561310 NCBI chr11:62,254,543...62,293,414
Ensembl chr11:62,254,624...62,292,030 		JBrowse link
G Cd86 CD86 molecule multiple interactions ISO Niclosamide inhibits the reaction [Lipopolysaccharides affects the expression of CD86 protein] CTD PMID:24561310 NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818 		JBrowse link
G Cdc37 cell division cycle 37, HSP90 cochaperone multiple interactions ISO CDC37 protein binds to and results in increased susceptibility to Niclosamide analog CTD PMID:28284560 NCBI chr 8:19,677,400...19,690,761
Ensembl chr 8:19,671,938...19,690,809 		JBrowse link
G Cdc42 cell division cycle 42 decreases expression
decreases phosphorylation		 ISO Niclosamide results in decreased expression of CDC42 mRNA
Niclosamide results in decreased phosphorylation of CDC42 protein		 CTD PMID:29251334 NCBI chr 5:149,555,069...149,593,239
Ensembl chr 5:149,553,724...149,593,111 		JBrowse link
G Cdc6 cell division cycle 6 decreases expression ISO Niclosamide results in decreased expression of CDC6 mRNA CTD PMID:28284560 NCBI chr10:83,864,189...83,878,011
Ensembl chr10:83,864,638...83,878,011 		JBrowse link
G Cdca2 cell division cycle associated 2 decreases expression ISO Niclosamide results in decreased expression of CDCA2 mRNA CTD PMID:28284560 NCBI chr15:41,895,946...41,942,226
Ensembl chr15:41,895,901...41,941,611 		JBrowse link
G Cdca5 cell division cycle associated 5 decreases expression ISO Niclosamide results in decreased expression of CDCA5 mRNA CTD PMID:28284560 NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:203,378,577...203,392,023 		JBrowse link
G Cdca8 cell division cycle associated 8 decreases expression ISO Niclosamide results in decreased expression of CDCA8 mRNA CTD PMID:28284560 NCBI chr 5:137,176,414...137,198,686
Ensembl chr 5:137,176,417...137,198,629 		JBrowse link
G Cdh1 cadherin 1 multiple interactions
increases expression		 ISO Niclosamide inhibits the reaction [[Lapatinib results in decreased susceptibility to Lapatinib] which results in decreased expression of CDH1 protein]; WNT7A protein affects the reaction [Niclosamide results in increased expression of CDH1 protein]
Niclosamide results in increased expression of CDH1 mRNA; Niclosamide results in increased expression of CDH1 protein		 CTD PMID:25174399 PMID:26643609 PMID:30143678 NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775 		JBrowse link
G Cdh2 cadherin 2 multiple interactions ISO Niclosamide inhibits the reaction [[Lapatinib results in decreased susceptibility to Lapatinib] which results in increased expression of CDH2 protein] CTD PMID:26643609 NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167 		JBrowse link
G Cdk2 cyclin dependent kinase 2 decreases expression ISO Niclosamide results in decreased expression of CDK2 protein CTD PMID:29031202 NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403 		JBrowse link
G Cdk4 cyclin-dependent kinase 4 decreases expression ISO Niclosamide results in decreased expression of CDK4 protein CTD PMID:29031202 NCBI chr 7:62,885,647...62,889,562
Ensembl chr 7:62,883,105...62,942,403 		JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression		 ISO TP53 gene mutant form inhibits the reaction [Niclosamide results in increased expression of CDKN1A mRNA]; TP53 protein mutant form inhibits the reaction [Niclosamide results in increased expression of CDKN1A mRNA] CTD PMID:30258081 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585 		JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 decreases expression ISO Niclosamide results in decreased expression of CDKN3 mRNA CTD PMID:28284560 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:20,022,664...20,033,945 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 increases expression ISO Niclosamide results in increased expression of CELSR3 mRNA CTD PMID:28284560 NCBI chr 8:109,530,597...109,558,360
Ensembl chr 8:109,530,641...109,558,354 		JBrowse link
G Cenpa centromere protein A decreases expression ISO Niclosamide results in decreased expression of CENPA mRNA CTD PMID:28284560 NCBI chr 6:25,700,142...25,711,767
Ensembl chr 6:25,700,142...25,711,675 		JBrowse link
G Cfp complement factor properdin increases expression ISO Niclosamide results in increased expression of CFP mRNA CTD PMID:28284560 NCBI chr  X:1,162,014...1,167,576
Ensembl chr  X:1,161,979...1,167,573 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex multiple interactions ISO Niclosamide results in decreased phosphorylation of and affects the localization of CHUK protein CTD PMID:26116531 NCBI chr 1:242,959,539...242,995,066
Ensembl chr 1:242,959,760...242,995,065 		JBrowse link
G Col1a1 collagen type I alpha 1 chain decreases expression ISO Niclosamide results in decreased expression of COL1A1 mRNA CTD PMID:28824321 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624 		JBrowse link
G Colec10 collectin subfamily member 10 increases expression ISO Niclosamide results in increased expression of COLEC10 mRNA CTD PMID:28284560 NCBI chr 7:85,744,895...85,806,368
Ensembl chr 7:85,744,895...85,805,675 		JBrowse link
G Crebbp CREB binding protein increases expression ISO Niclosamide results in increased expression of CREBBP mRNA CTD PMID:22576131 NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888 		JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions ISO Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ACP5 mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of and affects the localization of NFATC1 protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CASP3 protein modified form]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of FOS mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of ITGB3 mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of MMP9 mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of OCSTAMP mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of OSCAR mRNA]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TRAF6 protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of MAPK1 protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of MAPK3 protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of MAPK8 protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of MAPK9 protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of NFKBIA protein]; Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased phosphorylation of RELA protein] CTD PMID:28824321 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 multiple interactions ISO Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of CSGALNACT1 mRNA] CTD PMID:27542212 NCBI chr16:20,995,210...21,330,586
Ensembl chr16:21,235,784...21,330,319 		JBrowse link
G Csnk1e casein kinase 1, epsilon increases expression ISO Niclosamide results in increased expression of CSNK1E mRNA CTD PMID:22576131 NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794 		JBrowse link
G Csrnp1 cysteine and serine rich nuclear protein 1 increases expression ISO Niclosamide results in increased expression of CSRNP1 mRNA CTD PMID:28284560 NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183 		JBrowse link
G Ctbp1 C-terminal binding protein 1 increases expression ISO Niclosamide results in increased expression of CTBP1 mRNA CTD PMID:22576131 NCBI chr14:77,455,580...77,482,821
Ensembl chr14:77,455,696...77,482,821 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression
decreases expression
increases ubiquitination
decreases activity
multiple interactions		 ISO
EXP		 Niclosamide results in increased expression of CTNNB1 mRNA
Niclosamide results in decreased expression of CTNNB1 mRNA
Niclosamide results in increased ubiquitination of CTNNB1 protein
Niclosamide results in decreased activity of CTNNB1 protein
Niclosamide inhibits the reaction [Epinephrine results in increased phosphorylation of CTNNB1 protein]; Niclosamide inhibits the reaction [GCG protein results in increased phosphorylation of CTNNB1 protein]; Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CTNNB1 protein]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of CTNNB1 protein]]
Niclosamide analog results in decreased expression of CTNNB1 protein; Niclosamide results in decreased expression of CTNNB1 protein
Imatinib Mesylate promotes the reaction [Niclosamide results in decreased expression of CTNNB1 protein]; Niclosamide inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein]; Niclosamide inhibits the reaction [Lithium Chloride affects the localization of CTNNB1 protein]; Niclosamide inhibits the reaction [TNF protein affects the localization of CTNNB1 protein]; Niclosamide inhibits the reaction [WNT3A protein affects the localization of CTNNB1 protein]; Niclosamide inhibits the reaction [WNT3A protein results in increased stability of CTNNB1 protein]; Niclosamide promotes the reaction [Imatinib Mesylate results in decreased expression of CTNNB1 protein]		 CTD PMID:19772353 PMID:21531761 PMID:22576131 PMID:24534281 PMID:24552774 More... NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111 		JBrowse link
G Ctnnbip1 catenin, beta-interacting protein 1 multiple interactions ISO Niclosamide inhibits the reaction [CTNNB1 protein binds to CTNNBIP1 protein] CTD PMID:24534281 NCBI chr 5:159,961,961...160,010,942
Ensembl chr 5:159,961,928...160,010,939 		JBrowse link
G Ctsc cathepsin C decreases expression ISO Niclosamide results in decreased expression of CTSC protein CTD PMID:29480568 NCBI chr 1:142,028,386...142,059,841
Ensembl chr 1:142,028,392...142,060,387 		JBrowse link
G Ctsd cathepsin D decreases expression ISO Niclosamide results in decreased expression of CTSD protein CTD PMID:29480568 NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488 		JBrowse link
G Ctsk cathepsin K multiple interactions ISO Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of CTSK mRNA] CTD PMID:26792726 NCBI chr 2:183,058,586...183,069,551
Ensembl chr 2:183,058,569...183,069,550 		JBrowse link
G Cxcr5 C-X-C motif chemokine receptor 5 multiple interactions ISO Niclosamide affects the reaction [FAS protein mutant form affects the expression of CXCR5 mRNA] CTD PMID:33632240 NCBI chr 8:44,842,098...44,858,425
Ensembl chr 8:44,843,413...44,857,893 		JBrowse link
G Cycs cytochrome c, somatic increases expression ISO Niclosamide results in increased expression of CYCS protein CTD PMID:26703449 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 increases activity ISO Niclosamide results in increased activity of CYP1A1 protein CTD PMID:12451431 NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 decreases activity
increases expression		 ISO Niclosamide results in decreased activity of CYP1A2 protein
Niclosamide results in increased expression of CYP1A2 mRNA		 CTD PMID:11124226 PMID:28284560 NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312 		JBrowse link
G Cyp2d4 cytochrome P450, family 2, subfamily d, polypeptide 4 decreases activity ISO Niclosamide results in decreased activity of CYP2D6 protein CTD PMID:11124226 NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 increases expression ISO Niclosamide results in increased expression of CYP39A1 mRNA CTD PMID:28284560 NCBI chr 9:17,230,455...17,306,775
Ensembl chr 9:17,230,455...17,306,775 		JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases activity ISO Niclosamide results in decreased activity of CYP3A4 protein CTD PMID:11124226 NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions		 ISO Niclosamide results in increased expression of DDIT3 mRNA; Niclosamide results in increased expression of DDIT3 protein
ATF3 protein affects the reaction [Niclosamide results in increased expression of DDIT3 mRNA]		 CTD PMID:26917416 NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201 		JBrowse link
G Decr1 2,4-dienoyl-CoA reductase 1 decreases expression ISO Niclosamide results in decreased expression of DECR1 mRNA CTD PMID:22576131 NCBI chr 5:29,411,172...29,439,054
Ensembl chr 5:29,411,172...29,439,018 		JBrowse link
G Dmac2l distal membrane arm assembly component 2 like decreases expression ISO Niclosamide results in decreased expression of DMAC2L mRNA CTD PMID:22576131 NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933 		JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions ISO Niclosamide inhibits the reaction [PIK3CA protein modified form results in increased expression of DSCC1 mRNA] CTD PMID:27542212 NCBI chr 7:86,482,588...86,498,212
Ensembl chr 7:86,482,588...86,498,212 		JBrowse link
G Dvl1 dishevelled segment polarity protein 1 increases expression ISO Niclosamide results in increased expression of DVL1 mRNA CTD PMID:22576131 NCBI chr 5:166,456,989...166,468,733
Ensembl chr 5:166,456,686...166,468,664 		JBrowse link
G Dvl2 dishevelled segment polarity protein 2 decreases expression
multiple interactions		 ISO
EXP		 Niclosamide results in decreased expression of DVL2 protein
Niclosamide inhibits the reaction [Thioacetamide results in increased expression of DVL2 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of DVL2 mRNA]]		 CTD PMID:19772353 PMID:21531761 PMID:30143678 PMID:32961231 NCBI chr10:54,723,356...54,732,823
Ensembl chr10:54,723,411...54,732,820 		JBrowse link
G Dvl3 dishevelled segment polarity protein 3 increases expression ISO Niclosamide results in increased expression of DVL3 mRNA CTD PMID:22576131 NCBI chr11:80,365,446...80,382,641
Ensembl chr11:80,366,117...80,382,462 		JBrowse link
G E2f1 E2F transcription factor 1 decreases expression ISO Niclosamide results in decreased expression of E2F1 mRNA CTD PMID:29843133 NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361 		JBrowse link
G E2f8 E2F transcription factor 8 decreases expression ISO Niclosamide results in decreased expression of E2F8 mRNA CTD PMID:28284560 NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098 		JBrowse link
G Ebf1 EBF transcription factor 1 decreases expression ISO Niclosamide results in decreased expression of EBF1 mRNA CTD PMID:27226553 NCBI chr10:29,095,858...29,489,142
Ensembl chr10:29,099,933...29,487,665 		JBrowse link
G Echdc1 ethylmalonyl-CoA decarboxylase 1 decreases expression ISO Niclosamide results in decreased expression of ECHDC1 mRNA CTD PMID:22576131 NCBI chr 1:28,476,354...28,507,173
Ensembl chr 1:28,476,200...28,507,319 		JBrowse link
G Echs1 enoyl-CoA hydratase, short chain 1 decreases expression ISO Niclosamide results in decreased expression of ECHS1 mRNA CTD PMID:22576131 NCBI chr 1:194,895,036...194,903,863
Ensembl chr 1:194,895,036...194,903,884 		JBrowse link
G Egf epidermal growth factor decreases expression
multiple interactions		 ISO Niclosamide results in decreased expression of EGF mRNA; Niclosamide results in decreased expression of EGF protein
Niclosamide inhibits the reaction [EGF protein results in increased expression of HIF1A mRNA]; Niclosamide inhibits the reaction [EGF protein results in increased phosphorylation of STAT3 protein]		 CTD PMID:30779072 NCBI chr 2:218,219,408...218,302,370
Ensembl chr 2:218,219,415...218,302,064 		JBrowse link
G Egfr epidermal growth factor receptor decreases expression
decreases phosphorylation		 ISO Niclosamide analog results in decreased expression of EGFR protein; Niclosamide results in decreased expression of EGFR mRNA; Niclosamide results in decreased expression of EGFR protein
Niclosamide results in decreased phosphorylation of EGFR protein		 CTD PMID:28284560 PMID:28426875 PMID:30779072 NCBI chr14:91,176,931...91,349,722
Ensembl chr14:91,177,067...91,344,382 		JBrowse link
G Egr1 early growth response 1 increases expression ISO Niclosamide results in increased expression of EGR1 mRNA CTD PMID:28284560 NCBI chr18:26,463,333...26,465,531
Ensembl chr18:26,462,981...26,466,766 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 increases expression
multiple interactions		 ISO Niclosamide results in increased expression of EIF2AK3 mRNA
ATF3 protein affects the reaction [Niclosamide results in increased expression of EIF2AK3 mRNA]; Niclosamide results in increased expression of and results in increased phosphorylation of EIF2AK3 protein		 CTD PMID:26917416 NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2 subunit alpha increases phosphorylation ISO Niclosamide results in increased phosphorylation of EIF2S1 protein CTD PMID:26917416 NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225 		JBrowse link
G Eif4e eukaryotic translation initiation factor 4E multiple interactions ISO Niclosamide promotes the reaction [EIF4E protein binds to EIF4EBP1 protein] CTD PMID:19771169 NCBI chr 2:227,066,519...227,099,261
Ensembl chr 2:227,066,673...227,098,683 		JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 decreases expression
multiple interactions
decreases phosphorylation		 ISO Niclosamide analog results in decreased expression of EIF4EBP1 protein modified form; Niclosamide results in decreased expression of EIF4EBP1 protein modified form
Niclosamide inhibits the reaction [MTOR protein results in increased phosphorylation of EIF4EBP1 protein]; Niclosamide promotes the reaction [EIF4E protein binds to EIF4EBP1 protein]
Niclosamide results in decreased phosphorylation of EIF4EBP1 protein		 CTD PMID:19771169 PMID:28284560 PMID:30258081 NCBI chr16:64,792,595...64,805,984
Ensembl chr16:64,790,226...64,805,984 		JBrowse link
G Endod1 endonuclease domain containing 1 multiple interactions ISO Niclosamide inhibits the reaction [PIK3CA protein modified form results in increased expression of ENDOD1 mRNA] CTD PMID:27542212 NCBI chr 8:11,209,123...11,238,680
Ensembl chr 8:11,211,110...11,238,892 		JBrowse link
G Eno2 enolase 2 increases expression ISO Niclosamide results in increased expression of ENO2 mRNA CTD PMID:22576131 NCBI chr 4:157,572,085...157,580,971
Ensembl chr 4:157,572,088...157,580,980 		JBrowse link
G Eno3 enolase 3 decreases expression ISO Niclosamide results in decreased expression of ENO3 mRNA CTD PMID:22576131 NCBI chr10:55,370,531...55,375,921
Ensembl chr10:55,366,975...55,375,921 		JBrowse link
G Ep300 E1A binding protein p300 increases expression ISO Niclosamide results in increased expression of EP300 mRNA CTD PMID:22576131 NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088 		JBrowse link
G Eps8l3 EPS8 like 3 increases expression ISO Niclosamide results in increased expression of EPS8L3 mRNA CTD PMID:28284560 Ensembl chr 2:195,514,692...195,528,085 JBrowse link
G Fam83d family with sequence similarity 83, member D decreases expression ISO Niclosamide results in decreased expression of FAM83D mRNA CTD PMID:28284560 NCBI chr 3:147,421,941...147,441,211
Ensembl chr 3:147,421,908...147,441,192 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO
EXP		 Niclosamide affects the reaction [FAS protein mutant form affects the expression of BCL6 mRNA]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of BCL6 protein]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of CXCR5 mRNA]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of IL21 protein]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of IL6 protein]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of PRDM1 mRNA]; Niclosamide affects the reaction [FAS protein mutant form affects the expression of TCF7 protein]; Niclosamide affects the reaction [FAS protein mutant form affects the phosphorylation of STAT3 protein]; Niclosamide inhibits the reaction [Doxorubicin results in increased expression of FAS mRNA]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of FAS mRNA]		 CTD PMID:28318631 PMID:33632240 NCBI chr 1:231,798,963...231,832,591
Ensembl chr 1:231,798,960...231,832,591 		JBrowse link
G Fgf1 fibroblast growth factor 1 decreases expression ISO Niclosamide results in decreased expression of FGF1 mRNA; Niclosamide results in decreased expression of FGF1 protein CTD PMID:25174399 NCBI chr18:30,686,555...30,772,667
Ensembl chr18:30,686,581...30,772,357 		JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions
decreases expression		 ISO [Niclosamide co-treated with bicalutamide] results in decreased expression of FKBP5 mRNA
Niclosamide results in decreased expression of FKBP5 mRNA		 CTD PMID:28500234 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO Niclosamide inhibits the reaction [Doxorubicin results in increased expression of FN1 protein]
HIPK2 protein inhibits the reaction [Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]]; Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]		 CTD PMID:28318631 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Niclosamide inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of FOS mRNA]
Niclosamide inhibits the reaction [TNFSF11 protein results in increased expression of FOS protein]		 CTD PMID:26792726 PMID:28824321 NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036 		JBrowse link
G Fosb FosB proto-oncogene, AP-1 transcription factor subunit increases expression ISO Niclosamide results in increased expression of FOSB mRNA CTD PMID:28284560 NCBI chr 1:78,954,312...78,961,492
Ensembl chr 1:78,954,115...78,961,465 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Niclosamide results in increased expression of FOSL1 mRNA CTD PMID:22576131 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:202,754,529...202,764,930 		JBrowse link
G Foxm1 forkhead box M1 multiple interactions
decreases expression		 ISO Imatinib Mesylate promotes the reaction [Niclosamide results in decreased expression of FOXM1 protein]; Niclosamide inhibits the reaction [TNF protein affects the localization of FOXM1 protein]; Niclosamide promotes the reaction [Imatinib Mesylate results in decreased expression of FOXM1 protein] CTD PMID:27492973 NCBI chr 4:161,639,561...161,652,012
Ensembl chr 4:161,638,816...161,650,684 		JBrowse link
G Fscn1 fascin actin-bundling protein 1 multiple interactions ISO Niclosamide inhibits the reaction [Adenosine Triphosphate results in increased expression of FSCN1 mRNA] CTD PMID:29733962 NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211 		JBrowse link
G Fzd1 frizzled class receptor 1 affects localization ISO Niclosamide affects the localization of FZD1 protein CTD PMID:19772353 NCBI chr 4:29,310,303...29,314,701 JBrowse link
G Fzd2 frizzled class receptor 2 decreases expression ISO Niclosamide results in decreased expression of FZD2 mRNA CTD PMID:22576131 NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334 		JBrowse link
G Fzd5 frizzled class receptor 5 increases expression ISO Niclosamide results in increased expression of FZD5 mRNA CTD PMID:22576131 NCBI chr 9:66,117,370...66,119,127
Ensembl chr 9:66,113,112...66,121,457 		JBrowse link
G Fzd9 frizzled class receptor 9 decreases expression ISO Niclosamide results in decreased expression of FZD9 mRNA CTD PMID:22576131 NCBI chr12:21,427,084...21,429,398
Ensembl chr12:21,427,084...21,429,398 		JBrowse link
G Gcg glucagon multiple interactions EXP Niclosamide inhibits the reaction [GCG protein results in increased abundance of Cyclic AMP]; Niclosamide inhibits the reaction [GCG protein results in increased expression of CCND1 mRNA]; Niclosamide inhibits the reaction [GCG protein results in increased expression of CCND1 protein]; Niclosamide inhibits the reaction [GCG protein results in increased expression of MYC mRNA]; Niclosamide inhibits the reaction [GCG protein results in increased phosphorylation of CTNNB1 protein] CTD PMID:26964897 NCBI chr 3:47,113,914...47,122,929
Ensembl chr 3:47,113,914...47,122,929 		JBrowse link
G Got2 glutamic-oxaloacetic transaminase 2 increases expression ISO Niclosamide results in increased expression of GOT2 mRNA CTD PMID:22576131 NCBI chr19:9,174,304...9,199,995
Ensembl chr19:9,174,311...9,199,994 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta decreases expression
decreases phosphorylation		 ISO Niclosamide results in decreased expression of GSK3B mRNA
Niclosamide results in decreased phosphorylation of GSK3B protein		 CTD PMID:22576131 PMID:30143678 NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646 		JBrowse link
G Gtse1 G-2 and S-phase expressed 1 decreases expression ISO Niclosamide results in decreased expression of GTSE1 mRNA CTD PMID:28284560 NCBI chr 7:116,949,997...116,966,826
Ensembl chr 7:116,950,053...116,966,806 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase decreases expression ISO Niclosamide results in decreased expression of HADH mRNA CTD PMID:22576131 NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353 		JBrowse link
G Hamp hepcidin antimicrobial peptide decreases expression
increases expression		 ISO Niclosamide results in decreased expression of HAMP mRNA
Niclosamide results in increased expression of HAMP mRNA		 CTD PMID:25633564 PMID:28284560 NCBI chr 1:86,170,926...86,172,865
Ensembl chr 1:86,170,901...86,172,891 		JBrowse link
G Hbp1 HMG-box transcription factor 1 multiple interactions ISO Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of HBP1 mRNA] CTD PMID:27542212 NCBI chr 6:48,529,633...48,555,775
Ensembl chr 6:48,529,372...48,555,787 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 decreases expression
multiple interactions		 ISO
EXP		 Niclosamide results in decreased expression of HES1 protein
Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HES1 mRNA]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HES1 mRNA]; Niclosamide inhibits the reaction [Thioacetamide results in increased expression of HES1 mRNA]; Poloxamer promotes the reaction [Niclosamide inhibits the reaction [Thioacetamide results in increased expression of HES1 mRNA]]		 CTD PMID:19160421 PMID:28318631 PMID:32961231 NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192 		JBrowse link
G Hey1 hes-related family bHLH transcription factor with YRPW motif 1 multiple interactions ISO
EXP		 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HEY1 mRNA]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HEY1 mRNA]
Niclosamide inhibits the reaction [PIK3CA protein modified form results in decreased expression of HEY1 mRNA]		 CTD PMID:27542212 PMID:28318631 NCBI chr 2:93,096,706...93,100,316
Ensembl chr 2:93,095,498...93,100,312 		JBrowse link
G Hey2 hes-related family bHLH transcription factor with YRPW motif 2 multiple interactions
increases expression		 EXP
ISO		 Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HEY2 mRNA]
Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HEY2 mRNA]
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester inhibits the reaction [Niclosamide results in increased expression of HEY2 mRNA]		 CTD PMID:19160421 PMID:28318631 NCBI chr 1:26,822,131...26,832,218
Ensembl chr 1:26,822,131...26,832,218 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha decreases expression
multiple interactions		 ISO Niclosamide results in decreased expression of HIF1A mRNA; Niclosamide results in decreased expression of HIF1A protein
Niclosamide inhibits the reaction [EGF protein results in increased expression of HIF1A mRNA]		 CTD PMID:30779072 NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261 		JBrowse link
G Hipk2 homeodomain interacting protein kinase 2 multiple interactions ISO
EXP		 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HIPK2 mRNA]; Niclosamide inhibits the reaction [Doxorubicin results in increased expression of HIPK2 protein]
HIPK2 protein inhibits the reaction [Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of FN1 mRNA]]; HIPK2 protein inhibits the reaction [Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of VIM mRNA]]; HIPK2 protein inhibits the reaction [Niclosamide inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]]; Niclosamide inhibits the reaction [TGFB1 protein promotes the reaction [SMAD3 protein binds to HIPK2 promoter]]; Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HIPK2 protein]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HIPK2 mRNA]; Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of HIPK2 protein]		 CTD PMID:28318631 NCBI chr 4:67,439,327...67,619,223
Ensembl chr 4:67,440,501...67,619,223 		JBrowse link
G Hmmr hyaluronan-mediated motility receptor decreases expression ISO Niclosamide results in decreased expression of HMMR mRNA CTD PMID:28284560 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060 		JBrowse link
G Hoxa1 homeobox A1 increases expression ISO Niclosamide results in increased expression of HOXA1 CTD PMID:26820057 NCBI chr 4:81,255,814...81,258,504
Ensembl chr 4:81,255,883...81,258,504 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions ISO
EXP		 Niclosamide inhibits the reaction [Doxorubicin results in increased expression of ICAM1 mRNA]
Niclosamide inhibits the reaction [TGFB1 protein results in increased expression of ICAM1 mRNA]		 CTD PMID:28318631 NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438 		JBrowse link
G Igf1r insulin-like growth factor 1 receptor affects response to substance ISO IGF1R protein affects the susceptibility to Niclosamide CTD PMID:27497986 NCBI chr 1:121,549,839...121,838,545
Ensembl chr 1:121,550,743...121,831,777 		JBrowse link
G Igll1 immunoglobulin lambda-like polypeptide 1 decreases expression ISO Niclosamide results in decreased expression of IGLL1 mRNA CTD PMID:27226553 NCBI chr11:84,138,847...84,142,238
Ensembl chr11:84,138,910...84,142,216 		JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta affects localization ISO Niclosamide affects the localization of IKBKB protein CTD PMID:26116531 NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250 		JBrowse link
G Ikbkg inhibitor of nuclear factor